Kerafast is a Boston-based reagent company whose primary mission is to make unique laboratory-made research tools easily accessible to the global scientific community. Our portfolio includes cell lines, antibodies, small molecules, dyes and more, many of which are not available elsewhere. Since our founding in 2011, researchers from more than 200 institutions worldwide have made their innovative reagents available through our online platform, where the materials can be quickly accessed without needing to go through the traditional Material Transfer Agreement process.
We handle all selling and shipping logistics for the providing laboratory, as well as return generous royalty payments from every sale. We therefore help providing labs save time and resources, while generating extra funding for further research. Procuring scientists can more easily discover and access unique reagents that are often unavailable elsewhere, while also funding the work of other researchers. This creates a global community of scientists contributing and accessing Reagents for the Greater Good to accelerate their own research as well as scientific progress overall.
In 2018, Kerafast merged with Absolute Antibody, a UK-based company with a vision to make recombinant antibody technology available to all researchers. The merger brought together two companies with a shared commitment to improving the selection of research tools available to the scientific community.
Kerafast’s reagents come directly from the labs of life science researchers who have chosen to make their materials easily accessible to the global scientific community. Our portfolio offers many rare and one-of-a-kind research tools; in fact, more than 70% of our reagents cannot be found in any other commercial catalog.
Recombinant antibodies are manufactured using synthetic genes expressed in a defined in vitro cell line. Benefits include ensured reproducibility, high purity, low endotoxin levels, and more.
| Description | Catalog No. |
| Anti-Adenylate Cyclase Toxin [3D1] Antibody | EG8001 |
| Kf-Ab01117-1.1 | |
| Kf-Ab01117-23.0 | |
| Anti-Adenylate Cyclase Toxin [9D4] Antibody | EG8002 |
| Kf-Ab01118-2.0 | |
| Kf-Ab01118-23.0 | |
| nti-Advanced Glycation End Products (AGE), Methylglyoxal (MG) [3D11] Antibody | EMS301 |
| Kf-Ab01474-2.0 | |
| Kf-Ab01474-23.0 | |
| Anti-Aspergillus fumigatus [8A1] Antibody | EGA107 |
| EGA122 | |
| Kf-Ab01466-1.1 | |
| Kf-Ab01466-23.0 | |
| Anti-Burkholderia mallei BpaB [BpaB#4] Antibody | EGA074 |
| Kf-Ab01470-1.1 | |
| Kf-Ab01470-23.0 | |
| Anti-CD4, Cytoplasmic Tail [10C12] Antibody | EGA902 |
| Kf-Ab01465-1.1 | |
| Kf-Ab01465-23.0 | |
| Anti-Complement C3b-iC3b [7C12] Antibody | EG1004 |
| Kf-Ab01554-1.1 | |
| Anti-Detyrosinated Alpha Tubulin [AA12] Antibody | EG0039 |
| Kf-Ab01257-2.0 | |
| Kf-Ab01257-23.0 | |
| Anti-DNA-RNA Hybrid [S9.6] Antibody | ENH002 |
| ENH001 | |
| Kf-Ab01137-23.0 | |
| Kf-Ab01137-1.6 | |
| Kf-Ab01137-24.1 | |
| Kf-Ab01137-2.0 | |
| Anti-dsRNA [rJ2] Antibody | ES2001 |
| Kf-Ab01299-1.6 | |
| Kf-Ab01299-2.0 | |
| Kf-Ab01299-23.0 | |
| Anti-EGFRvIII [L8A4] Antibody | EDK002 |
| Kf-Ab00184-1.1 | |
| Kf-Ab00184-23.0 | |
| Anti-Ferret B Cell, Light Chain (Ig lambda) [4-D11] Antibody | EGA251 |
| Kf-Ab02370-1.1 | |
| Kf-Ab02370-23.0 | |
| Anti-Flavivirus E Protein [D1-4G2-4-15] Antibody | FCG001 |
| Kf-Ab00230-10.0 | |
| Kf-Ab00230-15.0 | |
| Kf-Ab00230-2.0 | |
| Kf-Ab00230-21.0 | |
| Anti-GABA-A Receptor, Gamma 2 Subunit [10F10-C1-B8] Antibody | EG1401 |
| Kf-Ab01119-23.0 | |
| Kf-Ab01119-3.0 | |
| Anti-IgE [R1E4] Antibody | ET0004 |
| Kf-Ab01270-1.1 | |
| Kf-Ab01270-23.0 | |
| Anti-IgG [8E11] Antibody | ET0004 |
| Kf-Ab01270-1.1 | |
| Kf-Ab01270-23.0 | |
| Anti-IgG, Macaque Pan-Species [1B3] Antibody | ET0001 |
| Kf-Ab01269-1.1 | |
| Kf-Ab01269-23.0 | |
| Anti-IgG, Marmoset Species-Specific [4H12] Antibody | ET0009 |
| Kf-Ab01273-23.0 | |
| Kf-Ab01273-3.0 | |
| Anti-IL-2RB (CD122) [5H4] Antibody | EMI024 |
| Kf-Ab01372-23.0 | |
| Anti-IL-2RG (CD132) [3E12] Antibody | EMI023 |
| Kf-Ab01370-2.0 | |
| Kf-Ab01370-23.0 | |
| Anti-IMP Dehydrogenase [1D6-3E] Antibody | EZ2001 |
| Kf-Ab02556-10.0 | |
| Kf-Ab02556-10.3 | |
| Kf-Ab02556-23.0 | |
| Kf-Ab02556-3.0 | |
| f-Ab02556-3.3 | |
| Anti-MHC Class I H2 Kb [AF6-88.5.5.3] Antibody | EZ1002 |
| Kf-Ab02570-10.0 | |
| Kf-Ab02570-10.3 | |
| Kf-Ab02570-2.0 | |
| Kf-Ab02570-2.3 | |
| Kf-Ab02570-23.0 | |
| Anti-MHC Class I H2 Kd, a3 Domain [SF1-1.1.1] Antibody | EZ1003 |
| Kf-Ab02575-23.0 | |
| Kf-Ab02575-4.0 | |
| Kf-Ab02575-4.3 | |
| Anti-MHC Class I H2 Kk [AF3-12.1.3] Antibody | EZ1001 |
| Kf-Ab02571-1.1 | |
| Kf-Ab02571-23.0 | |
| Anti-Myc tag [9E10] Antibody | FCG016 |
| Kf-Ab00100-24.1 | |
| Kf-Ab00100-22.0 | |
| Kf-Ab00100-10.6 | |
| Kf-Ab00100-16.0 | |
| Kf-Ab00100-14.0 | |
| Kf-Ab00100-10.0 | |
| Kf-Ab00100-11.0 | |
| Kf-Ab00100-12.1 | |
| Kf-Ab00100-13.0 | |
| Kf-Ab00100-15.0 | |
| Kf-Ab00100-3.0 | |
| Kf-Ab00100-1.7 | |
| Kf-Ab00100-2.0 | |
| Kf-Ab00100-1.6 | |
| Kf-Ab00100-1.1 | |
| Kf-Ab00100-20.0 | |
| Kf-Ab00100-4.0 | |
| Kf-Ab00100-21.0 | |
| Kf-Ab00100-23.0 | |
| Kf-Ab00100-6.6 | |
| Kf-Ab00100-6.1 | |
| Kf-Ab00100-7.1 | |
| Kf-Ab00100-8.1 | |
| Anti-Orthopoxvirus [VACV-5B1] Antibody | EGO015 |
| Kf-Ab02220-2.0 | |
| Kf-Ab02220-15.0 | |
| Kf-Ab02220-23.0 | |
| Anti-Ovalbumin [F2-3.58] Antibody | EZ0001 |
| Kf-Ab02576-1.1 | |
| Kf-Ab02576-23.0 | |
| Anti-OxPL [10C12] Antibody | EG1050 |
| Kf-Ab02915-21.0 | |
| Kf-Ab02915-23.0 | |
| Anti-Puromycin [3RH11] Antibody | EQ0001 |
| Kf-Ab02366-1.1 (EQ0001) | |
| Kf-Ab02366-10.0 | |
| Kf-Ab02366-23.0 | |
| Kf-Ab02366-21.0 | |
| Anti-RAGE, V Domain [2A11] Antibody | ENS001 |
| Kf-Ab01230-1.1 | |
| Kf-Ab01230-23.0 | |
| Anti-Sendai Virus HN Protein [1A6] Antibody | EMS016 |
| Kf-Ab01473-2.0 | |
| Kf-Ab01473-23.0 | |
| Anti-Tau [PC1C6] Antibody | EG7001 |
| Kf-Ab01120-2.0 | |
| Kf-Ab01120-23.0 | |
| Anti-Tetanus Toxoid Heavy Chain Fragment C G(T1b) [81H10] Antibody | EFD008 |
| Kf-Ab02615-3.0 | |
| Kf-Ab02615-10.0 | |
| Anti-TSH Beta (ovine/canine) [14H9.E4.A4] Antibody | EGA201 |
| Kf-Ab01469-1.1 | |
| Kf-Ab01469-23.0 | |
| Anti-VSV-G [8G5F11] Antibody | EB0010 |
| Kf-Ab01401-10.0 | |
| Kf-Ab01401-2.0 | |
| Kf-Ab01401-2.3 | |
| Kf-Ab01401-23.0 | |
| Anti-VSV-G [IE9F9] Antibody | EB0012 |
| Kf-Ab01402-10.0 | |
| Kf-Ab01402-10.3 | |
| Kf-Ab01402-15.0 | |
| Kf-Ab01402-2.0 | |
| Kf-Ab01402-2.3 | |
| Kf-Ab01402-21.0 | |
| Kf-Ab01402-23.0 | |
| Anti-VSV-M [23H12] Antibody | EB0011 |
| Kf-Ab01404-10.0 | |
| Kf-Ab01404-10.3 | |
| Kf-Ab01404-15.0 | |
| Kf-Ab01404-2.0 | |
| Kf-Ab01404-2.3 | |
| Kf-Ab01404-21.0 | |
| Kf-Ab01404-23.0 | |
| Anti-VSV-N [10G4] Antibody | EB0009 |
| Kf-Ab01403-10.0 | |
| Kf-Ab01403-10.3 | |
| Kf-Ab01403-15.0 | |
| Kf-Ab01403-2.0 | |
| Kf-Ab01403-2.3 | |
| Kf-Ab01403-21.0 | |
| Kf-Ab01403-23.0 | |
| Anti-Zaire Ebola Virus VP35 Protein, C-Terminal [6C5] Antibody | EMS702 |
| Kf-Ab01229-2.0 | |
| Kf-Ab01229-23.0 | |
| COVID-19/SARS-CoV Nucleoprotein [CR3009 (03-009)] Antibodies | Kf-Ab01691-10.0 |
| Kf-Ab01691-23.0 | |
| COVID-19/SARS-CoV Nucleoprotein [CR3018 (03-018)] Antibodies | Kf-Ab01690-10.0 |
| Kf-Ab01690-23.0 | |
| COVID-19/SARS-CoV S glycoprotein [CR3022] Antibodies | Kf-Ab01680-10.0 |
| Kf-Ab01680-23.0 | |
| IL-18 Antibodies | EUS040 |
| Kf-Ab02601-1.1 | |
| Kf-Ab02601-23.0 | |
| EUS041 | |
| Kf-Ab02602-2.0 | |
| Kf-Ab02602-2.3 | |
| Kf-Ab02602-23.0 | |
| EUS042 | |
| EUS043 | |
| IL-1-beta Antibodies | EUS018 |
| Kf-Ab02591-23.0 | |
| Kf-Ab02591-3.0 | |
| Kf-Ab02591-3.3 | |
| EUS019 | |
| Kf-Ab02592-1.1 | |
| Kf-Ab02592-23.0 | |
| EUS020 | |
| EUS021 | |
| EUS022 | |
| IL-4 Antibodies | EUS003 |
| EUS004 | |
| EUS005 | |
| EUS006 | |
| Kf-Ab02589-2.0 | |
| Kf-Ab02589-2.3 | |
| Kf-Ab02589-23.0 | |
| EUS007 | |
| EUS008 | |
| EUS009 | |
| EUS010 | |
| Recombinant Human ACE2-IgG Fc (LALA)-Fusion Protein | Kf-Pr00439 |
| Recombinant Human ACE2-NN-IgG Fc (LALA)-Fusion Protein | Kf-Pr00441 |
| Recombinant MERS S1-camel Fc-Fusion Protein | Kf-Pr00251 |
| Description | Catalog No. |
| Anti-IgG [8E11] Antibody | ET0004 |
| Kf-Ab01270-1.1 | |
| Kf-Ab01270-23.0 | |
| Anti-IgG, Macaque Pan-Species [1B3] Antibody | ET0001 |
| Kf-Ab01269-1.1 | |
| Kf-Ab01269-23.0 | |
| Anti-IgG, Marmoset Pan-Species [2B11] Antibody | ET0007 |
| Anti-IgG, Marmoset Species-Specific [4H12] Antibody | ET0009 |
| Kf-Ab01273-23.0 | |
| Kf-Ab01273-3.0 | |
| Anti-IgG-Biotin, Marmoset Pan-Species [2B11-Biotin] Antibody | ET0008 |
| Description | Catalog No. |
| Anti-6His Tag [8F9] Antibody | FCG019 |
| Anti-Actin [mAbGEa] Universal Antibody | EGA004 |
| Anti-Actin-1 [mAb45a] Antibody | EGA002 |
| Anti-Actin-11 [mAb2345a] Antibody | EGA003 |
| Anti-Actin-2 [mAb13a] Antibody | EGA001 |
| Anti-Actin-8 [mAbGPa] Antibody | EGA005 |
| Anti-Alpha Tubulin, Neuronal [AA13] Antibody | EG0040 |
| Anti-Angiotensin II Universal Antibody | EB7002 |
| Anti-AP-Tag [EF10] Antibody | EGO016 |
| Anti-Beta Tubulin [AA2] Antibody | EG0035 |
| Anti-DDDDK (flag-tag) [19E3] Antibody | FCG024 |
| Anti-DYKDDDDK (FLAG) Tag [2G11-C6-G9] Antibody | ESP001 |
| Anti-GFP [7A1] Antibody | FCG018 |
| Anti-GFP Tag [CG099] Antibody | FCG002 |
| Anti-GST [5C12] Antibody | FCG003 |
| Anti-Histone [F152C25W] Universal Antibody | EMZ103 |
| Anti-LacI [9A5] Universal Antibody | EG1501 |
| Anti-MBP [BBMBP23.42] Antibody | ESG016 |
| Anti-Myc tag (ChIP grade) [5A5] Antibody | FCG017 |
| Anti-Myc tag [9E10] Antibody | FCG016 |
| Kf-Ab00100-24.1 | |
| Kf-Ab00100-22.0 | |
| Kf-Ab00100-10.6 | |
| Kf-Ab00100-16.0 | |
| Kf-Ab00100-14.0 | |
| Kf-Ab00100-10.0 | |
| Kf-Ab00100-11.0 | |
| Kf-Ab00100-12.1 | |
| Kf-Ab00100-13.0 | |
| Kf-Ab00100-15.0 | |
| Kf-Ab00100-3.0 | |
| Kf-Ab00100-1.7 | |
| Kf-Ab00100-2.0 | |
| Kf-Ab00100-1.6 | |
| Kf-Ab00100-1.1 | |
| Kf-Ab00100-20.0 | |
| Kf-Ab00100-4.0 | |
| Kf-Ab00100-21.0 | |
| Kf-Ab00100-23.0 | |
| Kf-Ab00100-6.6 | |
| Kf-Ab00100-6.1 | |
| Kf-Ab00100-7.1 | |
| Kf-Ab00100-8.1 | |
| Anti-Survival Motor Neuron (SMN) [4B7] Universal Antibody | EMZ101 |
| Anti-TagRFP [6A11f] Antibody | EFH005 |
| Goat Anti-GAPDH (C Terminus) Loading Control Antibody | EB06377 |
| Description | Catalog No. |
| Alkyne-Carboxyrhodamine 110 | FCC905 |
| FCC127 | |
| Alkyne-PEG4-Acid | FCC115 |
| FCC116 | |
| Alkyne-PEG4-Amine | FCC112 |
| FCC113 | |
| Alkyne-PEG4-Biotin Conjugate | FCC125 |
| Alkyne-PEG4-Maleimide | FCC121 |
| FCC122 | |
| Alkyne-PEG4-NHS Ester | FCC118 |
| FCC119 | |
| Alkyne-TAMRA | FCC131 |
| Anti-Digoxigenin Antibody | AB-001 |
| Azide-Carboxyrhodamine 110 | FCC901 |
| FCC098 | |
| Azide-PEG3-Amine | FCC071 |
| FCC072 | |
| Azide-PEG3-Maleimide kit | FCC080 |
| FCC081 | |
| Azide-PEG4-Acid | FCC074 |
| FCC075 | |
| Azide-PEG4-NHS Ester | FCC077 |
| FCC078 | |
| Azide-TAMRA | FCC102 |
| Azidobutyric acid NHS ester | FLP001 |
| FLP002 | |
| FLP003 | |
| Azido-Propylamine | FCC108 |
| FCC327 | |
| Biotin-PEG3-Azide | FCC083 |
| FCC084 | |
| Bis-sulfone Acid | FCC374 |
| FCC375 | |
| Bis-sulfone NHS Ester | FCC378 |
| FCC379 | |
| Coumarin 343 azide | FLP082 |
| FLP083 | |
| FLP084 | |
| Cy3 – Alkyne | FCC154 |
| FCC155 | |
| Cy3 – Azide | FCC147 |
| FCC148 | |
| Cy3 – maleimide | FLP163 |
| FLP164 | |
| FLP165 | |
| FLP166 | |
| Cy3 – Methyltetrazine | FCC221 |
| FCC222 | |
| Cy3 azide | FLP015 |
| FLP016 | |
| FLP017 | |
| Cy3 azide, 10mM in DMSO | FLP012 |
| FLP013 | |
| FLP014 | |
| Cy3 carboxylic acid | FLP175 |
| FLP176 | |
| FLP177 | |
| FLP178 | |
| Cy3 NHS ester | FLP124 |
| FLP125 | |
| FLP126 | |
| FLP127 | |
| FLP128 | |
| Cy3.5 azide, 10mM in DMSO | FLP018 |
| FLP019 | |
| FLP020 | |
| Cy3.5 NHS ester | FLP129 |
| FLP130 | |
| FLP131 | |
| Cy5 – Alkyne | FCC157 |
| FCC156 | |
| Cy5 – Azide | FCC149 |
| FCC150 | |
| Cy5 – Methyltetrazine | FCC223 |
| FCC224 | |
| Cy5 azide | FLP024 |
| FLP025 | |
| FLP026 | |
| FLP027 | |
| FLP028 | |
| Cy5 azide, 10mM in DMSO | FLP021 |
| FLP022 | |
| FLP023 | |
| Cy5 Boc-hydrazide | FLP160 |
| FLP161 | |
| FLP162 | |
| Cy5 carboxylic acid | FLP179 |
| FLP180 | |
| FLP181 | |
| FLP182 | |
| FLP183 | |
| Cy5 hydrazide | FLP156 |
| FLP157 | |
| FLP158 | |
| FLP159 | |
| Cy5 Maleimide | FCC557 |
| FCC558 | |
| FCC559 | |
| FCC560 | |
| Cy5 Maleimide, 5 x 0.5 mg | FCC556 |
| Cy5.5 Azide | FCC339 |
| FCC340 | |
| FCC341 | |
| FCC342 | |
| Cy5.5 azide, 10mM in DMSO | FLP032 |
| FLP033 | |
| FLP034 | |
| FLP035 | |
| FLP036 | |
| FLP029 | |
| FLP030 | |
| FLP031 | |
| Cy5.5 carboxylic acid | FLP184 |
| FLP185 | |
| FLP186 | |
| FLP187 | |
| Cy5.5 Maleimide | FCC580 |
| FCC581 | |
| FCC582 | |
| FCC583 | |
| Cy7 Azide | FCC343 |
| FCC344 | |
| FCC345 | |
| FCC346 | |
| Cy7 azide, 10 mM in DMSO | FLP040 |
| FLP037 | |
| FLP038 | |
| FLP039 | |
| FLP041 | |
| FLP042 | |
| Cy7 carboxylic acid | FLP188 |
| FLP189 | |
| FLP190 | |
| FLP191 | |
| FLP192 | |
| Cy7 NHS ester | FLP142 |
| FLP143 | |
| FLP144 | |
| FLP145 | |
| FLP146 | |
| Cy7.5 azide | FLP046 |
| FLP047 | |
| FLP048 | |
| FLP049 | |
| FLP050 | |
| Cy7.5 azide, 10 mM in DMSO | FLP043 |
| FLP044 | |
| FLP045 | |
| Cy7.5 carboxylic acid | FLP193 |
| FLP194 | |
| FLP195 | |
| FLP196 | |
| FLP197 |
| Description | Catalog No. |
| Cy7.5 NHS ester | FLP151 |
| FLP147 | |
| FLP148 | |
| FLP149 | |
| FLP150 | |
| DBCO-Carboxyrhodamine 110 | FCC052 |
| FCC053 | |
| FCC271 | |
| DBCO-Maleimide | FCC022 |
| FCC023 | |
| FCC024 | |
| DBCO-NHS ester | FCC008 |
| FCC009 | |
| FCC010 | |
| DBCO-PEG 10 kDa | FCC062 |
| FCC063 | |
| DBCO-PEG 20 kDa | FCC064 |
| FCC065 | |
| DBCO-PEG 30 kDa | FCC066 |
| FCC067 | |
| DBCO-PEG 5 kDa | FCC060 |
| FCC061 | |
| DBCO-PEG4-Alcohol | FCC030 |
| FCC031 | |
| FCC032 | |
| DBCO-PEG4-Amine | FCC020 |
| FCC021 | |
| DBCO-PEG4-Biotin | FCC038 |
| FCC039 | |
| DBCO-PEG4-Maleimide | FCC026 |
| FCC027 | |
| FCC028 | |
| FCC025 | |
| DBCO-PEG4-NHS ester | FCC011 |
| FCC012 | |
| FCC013 | |
| FCC014 | |
| DBCO-TAMRA | FCC054 |
| FCC055 | |
| FCC272 | |
| FAM azide, 5- isomer | FLP054 |
| FLP055 | |
| FLP056 | |
| FLP057 | |
| FAM azide, 5- isomer, 10 mM in DMSO | FLP051 |
| FLP052 | |
| FLP053 | |
| FAM azide, 6- isomer | FLP061 |
| FLP062 | |
| FLP063 | |
| FLP064 | |
| FAM azide, 6- isomer, 10 mM in DMSO | FLP058 |
| FLP059 | |
| FLP060 | |
| Lys-to-Lys Protein-Protein Conjugation Kit | FCC595 |
| Methyltetrazine-PEG4-Alkyne | FCC212 |
| FCC213 | |
| FCC214 | |
| Methyltetrazine-PEG4-Azide | FCC215 |
| FCC216 | |
| FCC217 | |
| Methyltetrazine-PEG4-Maleimide | FCC209 |
| FCC210 | |
| FCC211 | |
| Methyltetrazine-PEG4-NHS Ester | FCC204 |
| FCC205 | |
| FCC206 | |
| FCC207 | |
| Pentynoic acid STP ester | FLP097 |
| PEP azide | FLP088 |
| FLP089 | |
| FLP090 | |
| Perylene azide | FLP091 |
| FLP092 | |
| FLP093 | |
| Propargyl-Maleimide | FCC152 |
| FCC153 | |
| Propargyl-NHS ester | FCC138 |
| FCC139 | |
| ROX azide, 5- isomer, 10 mM in DMSO | FLP071 |
| FLP072 | |
| FLP073 | |
| ROX NHS ester, pure 6- isomer | FLP152 |
| FLP153 | |
| FLP154 | |
| FLP155 | |
| Sulfo-Cy3 azide | FLP004 |
| FLP005 | |
| FLP006 | |
| FLP007 | |
| Sulfo-Cy3 NHS ester | FLP109 |
| FLP110 | |
| FLP111 | |
| FLP112 | |
| FLP113 | |
| Sulfo-Cy5 azide | FLP008 |
| FLP009 | |
| FLP010 | |
| FLP011 | |
| Sulfo-Cy5 carboxylic acid | FLP174 |
| Sulfo-Cy5 NHS ester | FLP114 |
| FLP115 | |
| FLP116 | |
| FLP117 | |
| FLP118 | |
| Sulfo-Cy5 azide | FLP008 |
| FLP009 | |
| FLP010 | |
| FLP011 | |
| Sulfo-Cy5 carboxylic acid | FLP174 |
| Sulfo-Cy5 NHS ester | FLP114 |
| FLP115 | |
| FLP116 | |
| FLP117 | |
| FLP118 | |
| Sulfo-Cy7 NHS ester | FLP119 |
| FLP120 | |
| FLP121 | |
| FLP122 | |
| FLP123 | |
| TAMRA azide, 5- isomer | FLP077 |
| FLP078 | |
| FLP079 | |
| FLP080 | |
| FLP081 | |
| TAMRA azide, 5- isomer, 10 mM in DMSO | FLP074 |
| FLP075 | |
| FLP076 | |
| TCO-Amine, HCl salt | FCC198 |
| FCC199 | |
| FCC200 | |
| TCO-NHS ester | FCC195 |
| FCC196 | |
| FCC197 | |
| TCO-PEG3-Maleimide | FCC188 |
| FCC189 | |
| FCC190 | |
| FCC191 | |
| TCO-PEG4-NHS ester | FCC184 |
| FCC185 | |
| FCC186 | |
| FCC187 | |
| Tetrazine-DBCO | FCC218 |
| FCC219 | |
| FCC220 | |
| Z-Cy2 Maleimide | EMT004 |
| Z-Cy2 NHS Ester | EMT001 |
| Z-Cy2 Thiol | EMT007 |
| Z-Cy3 Maleimide | EMT005 |
| Z-Cy3 NHS Ester | EMT002 |
| Z-Cy3 Thiol | EMT008 |
| Z-Cy5 Maleimide | EMT006 |
| Z-Cy5 NHS Ester | EMT003 |
| Z-Cy5 Thiol | EMT009 |
Fc-Fusion proteins (also known as Fc chimeric fusion proteins, Fc-Ig’s, Ig-based Chimeric Fusion proteins and Fc-tag proteins) are composed of the Fc domain of IgG genetically linked to a peptide or protein of interest. Fc-Fusion proteins have become valuable reagents for in vivo and in vitro research.
Examples of Fc-fused binding partners include, but are not limited to, single peptides, ligands activated upon cell-surface receptor binding, signaling molecules, extracellular domains of receptors activated upon dimerization and bait proteins used to identify binding partners in protein microarrays.
One of the most valuable characteristics conferred by the Fc domain in vivo is the dramatic prolonging of the plasma half-life (t1/2) of the protein of interest, which for biotherapeutic drugs can result in improved therapeutic efficacy; an attribute that has made Fc-Fusion proteins attractive biotherapeutic agents.
In vitro applications of Fc-Fusion proteins include, amongst others, immunohistochemistry (IHC), flow cytometry (FC), protein binding assays and use as microarray baits. In these applications, the Fc domain behaves as a supporting module to which proteins can be attached whilst retaining their native biological activity. The Fc domain can also improve the in vivo and in vitro solubility and stability of some binding partners.
We’re excited to offer a large selection of Fc-Fusion proteins from our sister company Absolute Antibody, which specializes in engineering unique recombinant antibodies and proteins.
| Description | Catalog No. |
| Immunoglobulin Fc domains | Kf-Pr00343-38.5 |
| Kf-Pr00344-39.5 | |
| Kf-Pr00345-40.5 | |
| Kf-Pr00105-16.5 | |
| Kf-Pr00104-14.5 | |
| Kf-Pr00100-10.5 | |
| Kf-Pr00108-15.5 | |
| Kf-Pr00107-20.5 | |
| Kf-Pr00101-1.5 | |
| Kf-Pr00102-2.5 | |
| Recombinant Human ACE2-IgG Fc (LALA)-Fusion Protein | Kf-Pr00439 |
| Recombinant Human ACE2-NN-IgG Fc (LALA)-Fusion Protein | Kf-Pr00441 |
| Recombinant human CADM1 Fc-Fusion Protein | Kf-Pr00236-10.9 |
| Recombinant human CD226 Fc-Fusion Protein | Kf-Pr00123-10.9 |
| Recombinant human CD69 Fc-Fusion Protein | Kf-Pr00186-10.28 |
| Recombinant human CTLA-4 Fc-Fusion Protein | Kf-Pr00103-10.13 |
| Recombinant human EGFR Fc-Fusion Protein | Kf-Pr00117-10.9 |
| Recombinant human NCAM1 Fc-Fusion Protein | Kf-Pr00241-10.9 |
| Recombinant human NCTR1 Fc-Fusion Protein | Kf-Pr00127-10.9 |
| Recombinant human NCTR3 Fc-Fusion Protein | Kf-Pr00126-10.9 |
| Recombinant human NKG2D Fc-Fusion Protein | Kf-Pr00125-10.28 |
| Recombinant human NKG2E Fc-Fusion Protein | Kf-Pr00128-10.28 |
| Recombinant human SLAF7 Fc-Fusion Protein | Kf-Pr00180-10.9 |
| Recombinant human TIGIT Fc-Fusion Protein | Kf-Pr00122-10.9 |
| Recombinant MERS S1-camel Fc-Fusion Protein | Kf-Pr00251 |
| Recombinant mouse 4-1BB Fc-Fusion Protein | Kf-Pr00233-1.9 |
| Recombinant mouse 4-1BBL Fc-Fusion Protein | Kf-Pr00159-1.28 |
| Recombinant mouse B7-H3 Fc-Fusion Protein | Kf-Pr00158-1.9 |
| Recombinant mouse BTLA Fc-Fusion Protein | Kf-Pr00224-1.9 |
| Recombinant mouse CD27 Fc-Fusion Protein | Kf-Pr00160-1.9 |
| Recombinant mouse CD47 (C33 to G mutation) Fc-Fusion Protein | Kf-Pr00113-1.9 |
| Recombinant Human ACE2-NN-IgG Fc (LALA)-Fusion Protein | Kf-Pr00441 |
| Recombinant mouse CD80 Fc-Fusion Protein | Kf-Pr00225-1.9 |
| Recombinant mouse CD86 Fc-Fusion Protein | Kf-Pr00226-1.9 |
| Recombinant mouse CD96 Fc-Fusion Protein | Kf-Pr00230-1.9 |
| Recombinant mouse CTLA4 Fc-Fusion Protein | Kf-Pr00155-1.9 |
| Recombinant mouse ICOS Fc-Fusion Protein | Kf-Pr00153-1.9 |
| Recombinant mouse ICOSL Fc-Fusion Protein | Kf-Pr00157-1.9 |
| Recombinant mouse IL2 Fc-Fusion Protein | Kf-Pr00109-1.9 |
| Recombinant mouse Lag3 Fc-Fusion Protein | Kf-Pr00162-1.9 |
| Recombinant mouse OX40 Fc-Fusion Protein | Kf-Pr00154-1.9 |
| Recombinant mouse PD-1 Fc-Fusion Protein | Kf-Pr00152-1.9 |
| Recombinant mouse PDL1 Fc-Fusion Protein | Kf-Pr00112-1.9 |
| Recombinant mouse PDL2 Fc-Fusion Protein | Kf-Pr00156-1.9 |
| Recombinant mouse TIGIT Fc-Fusion Protein | Kf-Pr00163-1.9 |
| Recombinant mouse TIM-1 Fc-Fusion Protein | Kf-Pr00227-1.9 |
| Recombinant mouse TIM-3 Fc-Fusion Protein | Kf-Pr00228-1.9 |
| Recombinant mouse TNFR1 Fc-Fusion Protein | Kf-Pr00111-1.9 |
| Recombinant mouse VISTA Fc-Fusion Protein | Kf-Pr00164-1.9 |
| Description | Catalog No. |
| Anti-Annexin A1 [74/3] Hybridoma | ESK018 |
| Anti-Annexin-2 [D1/274.5] Hybridoma | ESK005 |
| Anti-Aspergillus fumigatus [12A6] Antibody | EGA111 |
| EGA126 | |
| Anti-Aspergillus fumigatus [14B5] Antibody | EGA112 |
| EGA127 | |
| Anti-Aspergillus fumigatus [16C4] Antibody | EGA113 |
| EGA128 | |
| Anti-Aspergillus fumigatus [18A3] Antibody | EGA129 |
| EGA114 | |
| Anti-Aspergillus fumigatus [19H1] Antibody | EGA115 |
| EGA130 | |
| Anti-Aspergillus fumigatus [1C4] Antibody | EGA101 |
| EGA116 | |
| Anti-Aspergillus fumigatus [1D2] Antibody | EGA117 |
| EGA102 | |
| Anti-Aspergillus fumigatus [1E2] Antibody | EGA103 |
| EGA118 | |
| Anti-Aspergillus fumigatus [4G5] Antibody | EGA104 |
| EGA119 | |
| Anti-Aspergillus fumigatus [5D4] Antibody | EGA120 |
| EGA105 | |
| Anti-Aspergillus fumigatus [5H9] Antibody | EGA121 |
| EGA106 | |
| Anti-Aspergillus fumigatus [8A1] Antibody | EGA107 |
| EGA122 | |
| Kf-Ab01466-1.1 | |
| Kf-Ab01466-23.0 | |
| Anti-Aspergillus fumigatus [8C12] Antibody | EGA109 |
| EGA124 | |
| Anti-Aspergillus fumigatus [8C8] Antibody | EGA108 |
| EGA123 | |
| Anti-Aspergillus fumigatus [9F1] Antibody | EGA125 |
| EGA110 | |
| Anti-Bat Ig Light Chain [BT1-4F10] Hybridoma | EHR001 |
| Anti-CD11a [I21/7] Hybridoma | ESK007 |
| Anti-CD18 [C71/16] Hybridoma | ESK008 |
| Anti-CD22 [MARA 2.1.4] Hybridoma | ESK030 |
| Anti-CD24 [R7129.7] Hybridoma | ESK025 |
| nti-CD44 [IM7.8.1] Hybridoma | ESK006 |
| Anti-CD45 [I3/2.3] Hybridoma | ESK017 |
| Anti-CD45 [T29/33.6.1] Hybridoma | ESK004 |
| Anti-CD71 [42/6.3.1] Hybridoma | ESK009 |
| Anti-CD71 [A27.15] Hybridoma | ESK019 |
| Anti-CD71 [B3/25] Hybridoma | ESK020 |
| Anti-CD71 [H68.4] Hybridoma | ESK003 |
| Anti-CD71 [R17 217.1.4] Hybridoma | ESK014 |
| Anti-CD71 [RI7 208.2] Hybridoma | ESK028 |
| Anti-CD71 [T56/14] Hybridoma | ESK022 |
| Anti-CD90 [T24/31] Hybridoma | ESK029 |
| Anti-HLA-DP [B7/21] Hybridoma | ESK013 |
| Anti-LNFPIII/Lewis X (CD15) [E.5] Antibody | EGA072 |
| EGA073 | |
| Anti-Mycoplasma gallisepticum Surface Epitope Antibodies | EGA078 |
| EGA079 | |
| EGA080 | |
| EGA081 | |
| EGA082 | |
| EGA083 | |
| EGA084 | |
| EGA085 | |
| EGA086 | |
| EGA087 | |
| EGA088 | |
| EGA089 | |
| EGA090 | |
| EGA091 | |
| EGA092 | |
| EGA093 | |
| EGA094 | |
| EGA095 | |
| EGA096 | |
| EGA097 | |
| Anti-Mycoplasma hyopneumoniae Ciliary Adhesin Protein P97 [F1B6 ] Hybridoma | EIS001 |
| Anti-Phosphotyrosine [Py20] Hybridoma | ESK032 |
| Anti-Phosphotyrosine [Py72] Hybridoma | ESK016 |
| Anti-PLSCR1 [4D2] Hybridoma | EBW201 |
| Anti-PLSCR1 [MBC 219.1] Hybridoma | EBW202 |
| Anti-RNA Polymerase II [MARA 3] Hybridoma | ESK027 |
| Anti-Thymocyte B-Cell Antigen [RGRSL 114.8.1] Hybridoma | ESK012 |
| Anti-Tumor Necrosis Factor (TNF) [12F6] Antibody | EGA044 |
| EGA045 | |
| Anti-Tumor Necrosis Factor (TNF) [9B10] Antibody | EGA042 |
| EGA043 | |
| Anti-VCP [MARA 1.2] Hybridoma | ESK031 |
| Anti-Yersinia pestis [6B5] Hybridoma | EGA402 |
| B Cell Activating Feeder Cell Line (EL-4-B5) | EVU301 |
| Description | Catalog No. |
| ArborEasy® DNA Isolation Kit | EIF001 |
| Biotinylated sRNA Ladder | EGA701 |
| Bloo Moose™ Staining Solution | CE0730 |
| Broad Range DNA Ladder | ESA115 |
| KAZU DNA Extraction Buffer | EDD001 |
| EDD002 | |
| EDD003 | |
| MetalloBuffer BufferTM Kit pZn 11-7 | KPG003 |
| MetalloBuffer BufferTM Kit pZn 13-9 | KPG002 |
| Optimized ECL Reagent | ESL201 |
| Protein Buffers for Mass Spectrometric Immunoassay (MSIA) | EAS002 |
| EAS003 | |
| EAS001 |
| Description | Catalog No. |
| (10-Methyl-9-anthrylmethyl)-trimethyl ammonium chloride | EN0005 |
| (4-Methyl-1-napthylmethyl) trimethyl ammonium bromide | EN0008 |
| (4-Methylbenzoylmethyl)dimethylamine Hydrochloride | EN0087 |
| (5-Indanylmethyl)trimethylammonium Bromide | EN0085 |
| (5-Methyl-2-furfurylmethyl)trimethyl ammonium iodide | EN0007 |
| (5-Methyl-2-thienylmethyl) trimethyl ammonium iodide | EN0006 |
| (p-Tolylmethyl) trimethyl ammonium bromide | EN0009 |
| [1,1’-Bicyclohexyl]-1,1’-diol | EN0089 |
| [2.2](2,5)Furanophane (13,14-Dioxatricyclo[8.2.1.1^(4,7)]tetradeca-4,6,10,12-tetraene) | EN0061 |
| [2.2](2,5)N,Methylthiazolium(2,5)thiophenophane Iodide(13,14-Dithia-5-aza-5-N,methyltricyclo[8.2.1.1^(4,7)]tetradeca-4,6,10,12-tetraene Iodide) | EN0063 |
| [2.2](2,5)Thiazolium(1,4)paracyclophane Iodide (15-Thia-5-aza-5-N,methyltricyclo[8.2.1.1^(4,7)]pentadeca-4,6,10,12,13-pentaene Iodide) | EN0065 |
| [2.2](2,5)Thiazolo(1,4)paracyclophane(15-Thia-5-azatricyclo[8.2.1.1^(4,7)]pentadeca-4,6,10,12,13-pentaene) | EN0064 |
| [2.2](2,5)Thiazolo(2,5)furanophane (13-oxa-14-thia-5-azatricyclo[8.2.1.1^(4,7)]tetradeca-4,6,10,12-tetraene) | EN0060 |
| [2.2](2,5)Thiopheno(2,5)Thiazolophane (13,14-Dithia-5-azatricyclo[8.2.1.1^(4,7)]tetradeca-4,6,10,12-tetraene) | EN0062 |
| [2.2](3,5)isoxazolo(1,4)paracyclophane (5-Oxa-6-azatricyclo[8.2.1.1^(4,7)]pentadeca-4(15),6,10,12,13-pentaene) | EN0073 |
| [3.3]Disulphono(3,5)Isoxazolo(1,4)paracyclophane (6-Oxa-3,10-dithia-7-azatricyclo [10.2.2.1^(5,8)]heptadeca-5(17),7,12,14,15-pentaene-3,3,10,10-tetraoxide) | EN0076 |
| [3.3]Dithia(3,5)isoxazolo(1,3)metacyclophane (6-Oxa-3,10-dithia-7-azatricyclo[10.3.1.1^(5,8)]heptadeca-1(16),5(17),7,12,14-pentaene) | EN0071 |
| [3.3]Dithia(3,5)isoxazolo(1,3)metacyclophane (6-Oxa-3,10-dithia-7-azatricyclo[10.3.1.1^(5,8)]heptadeca-1(16),5(17),7,12,14-pentaene-2,2,11,11-d4) | EN0072 |
| [3.3]Dithia(3,5)isoxazolo(1,4)paracyclophane (6-Oxa-3,10-dithia-7-azatricyclo[10.2.2.1^(5,8)] heptadeca-5(17),7,12,14,15-pentaene) | EN0074 |
| 1-(2-Imidazoloethyl)-4-(2-hydroxyethyl)benzene | EN0028 |
| 1,1’-Diacetylferrocene | EN0078 |
| 1,2,3,6-Tetrahydro-1,2-benzenedicarboxylic acid, 3-(methoxymethyl)-6-methyl, anhydride | EN0101 |
| 1,2-Benzenedicarboxylic acid, 3-(methoxymethyl)-6-methyl-, dimethyl ester | EN0098 |
| 1,2-bis-(5-Carbethoxy-2-thiazolo)ethane | EN0066 |
| 1,2-bis-(5-Chloromethyl-2-thiazolo)ethane | EN0068 |
| 1,2-bis-(5-Hydroxymethyl-2-thiazolo)ethane | EN0067 |
| 1,2-Dicarbomethoxy-3-(benzyloxymethyl)-6-methyl-1,4-cyclohexadiene | EN0105 |
| 1,2-Dicarbomethoxy-3-(methoxymethyl)-6-methyl-1,4-cyclohexadiene | EN0106 |
| 1,3-bis-(1,3-dithian-2yl)benzene | EN0083 |
| 1,3-bis-(dideuterobromomethyl)benzene | EN0091 |
| 1,3-Cyclopentanedicarboxylic acid, 4,5-dioxo-, 1,3-diethyl ester | EN0109 |
| 1,3-Dithiane | EN0082 |
| 1,4-bis-(1,3-dithiolan-2-yl)benzene | EN0081 |
| 1,4-bis-(2-Bromoethyl)benzene | EN0023 |
| 1,4-bis-(2-Carbethoxyethyl)benzene | EN0031 |
| 1,4-bis-(2-Carboxyethyl)benzene | EN0024 |
| 1,4-bis-(2-Ferrocenoylethyl)benzene | EN0036 |
| 1,4-bis-(2-Hydroxyethyl)benzene dimesylate | EN0090 |
| 1,4-bis-(2-Hydroxyethyl)benzene mono Mesylate | EN0025 |
| 1,4-bis-(Chloromethylthiomethyl)benzene | EN0018 |
| 1,4-bis-(Hydroxymethylthiomethyl)benzene | EN0021 |
| 1,4-bis-(Tosylmethylthiomethyl)benzene | EN0022 |
| 1,4-Dicarbethoxy-1,3-cyclohexadiene:1,4-benzoquinone D.A. Adduct | EN0104 |
| 1,4-Dicarbomethoxy-1,3-cyclohexadiene | EN0108 |
| (5-Indanylmethyl)trimethylammonium Bromide | EN0085 |
| 1,5-Dicarbethoxy-4,8-dimethyl-1,4,5,8,9,10-decahydroanthracene-9,10-diol | EN0100 |
| 1,5-Dicarbethoxy-4,8-dimethyl-1,4,5,8-octahydroanthraquinone | EN0107 |
| 1,5-Dimethyl-4,8-dimethoxymethyl-9-anthrone | EN0016 |
| 1,5-Dimethyl-4,8-dimethoxymethylanthracene | EN0017 |
| 1-Bromo-4-(2-imidizoloethyl)benzene | EN0026 |
| 1-Carbethoxy-4-methyl-1,4,5,6-tetrahydro-9,10-anthraquinone | EN0102 |
| [2.2](2,5)Thiazolium(1,4)paracyclophane Iodide (15-Thia-5-aza-5-N,methyltricyclo[8.2.1.1^(4,7)]pentadeca-4,6,10,12,13-pentaene Iodide) | EN0065 |
| 2-(4-Methylbenzoyl)ethyltrimethylammonium Iodide | EN0088 |
| 2,5 dibromohexanediamide (DBHDA) | EOX103 |
| 3,5-Dicarbethoxyisoxazoline | EN0048 |
| 4-(2-Carbethoxyethenyl)benzaldehyde Ethylene Glycol Acetal | EN0030 |
| 4-(2-Carbethoxyethyl)benzaldehyde | EN0033 |
| 4-(2-Carbethoxyethyl)benzaldehyde Ethylene Glycol Acetal | EN0029 |
| 4-(2-Carboxyethenyl)benzaldehyde | EN0035 |
| 4-(2-Ferrocenoylethenyl)-1-(2-carboxyethyl)benzene | EN0039 |
| 4-(2-Ferrocenoylethenyl)benzaldehyde | EN0042 |
| 4-(2-Ferrocenoylethenyl)benzaldehyde Ethylene Glycol Acetal | EN0037 |
| 4-(2-Ferrocenoylethyl)-1-(2-carboxyethyl) benzene | EN0040 |
| 4-(3-Ferrocenylpropyl)-1-(2-carboxyethyl)benzene | EN0041 |
| 4,7,11-Trioxa-8-azatricyclo[12.2.2.1^(6,9)]nonadeca-6(19),8,14,16,17-pentaene-3,12-dione) | EN0077 |
| 4,7-Dimethylcoumarin | EN0043 |
| 4-Methoxy-1-(3-phenylpropenoyl)benzene | EN0034 |
| 5-(Carbethoxy)-2-methylthiazole | EN0047 |
| 5-(Dideuterochloromethyl)-2-methylthiazole | EN0046 |
| 5-(Dideuterohydroxymethyl)-2-methylthiazole | EN0045 |
| 5-(Hydroxymethyl)-3-carbethoxyisoxazole | EN0049 |
| 5-Methoxymethyl-8-methylnaphthoquinone | EN0015 |
| 5-Methyl-2-(N,N-dimethylamido)indanone | EN0086 |
| 6,21-Dioxa-3,10,17,24-tetrathia-7,20-diazapentacyclo[24.2.2.2^(12,15).2^(12,15).1^(19,22)] pentatriaconta-7,12,13,14,19,22(31),26,28,29-nonaene | EN0075 |
| 6-Methyl-5,10,8,9-tetrahydronaphthoquinone | EN0094 |
| 6-Methylnaphthoquinone | EN0095 |
| Acenaphthylene | EN0096 |
| Acetophenone Tosylhydrazone | EN0093 |
| Acetylferrocene | EN0038 |
| alpha-Bromo-4-methylpropiophenone | EN0084 |
| anti-anti-[2.2](2,5)N,Methylthiazolium (2,5)thiazolophane Iodide | EN0058 |
| anti-anti-[2.2](2,5)Oxazolophane (13,14-Dioxa-5,11-diazatricyclo[8.2.1.1^(4,7)]tetradeca-4,6,10,12-tetraene, anti-anti stereoisomer) | EN0069 |
| anti-anti-[2.2](2,5)Tetradeuterothiazolophane (13,14-Dithia-5,11-diaza-tricyclo[8.2.1.1^(4,7)]tetradeca-4,6,10,12-tetraene-2,2,8,8-d4, anti-anti stereoisomer) | EN0052 |
| anti-anti-[2.2](2,5)Thiazolophane (13,14-Dithia-5,11- diazatricyclo[8.2.1.1^(4,7)]tetradeca-4,6,10,12-tetraene, anti-anti stereoisomer) | EN0051 |
| anti-anti-[2.2](2,5)Thiazolophane(13,14-Dithia-5,11-diazatricyclo[8.2.1.1^(4,7)]tetradeca-4,6,10,12-tetraene,anti-anti,anti-syn stereoisomer) | EN0053 |
| anti-anti-[2.2](2,5)Thiazolophane(13,14-Dithia-5,11-diaza-tricyclo[8.2.1.1^(4,7)]-tetradeca-4,6,10,12-tetraene-2,2,8,8-d4,anti-anti,anti-syn stereoisomer) | EN0055 |
| anti-syn-[2.2](2,5)N,N-Dimethylthiazoliumcyclophane Diiodide | EN0059 |
| anti-syn-[2.2](2,5)Oxazolophane (13,14-Dioxa-5,12-diazatricyclo[8.2.1.1^(4,7)]tetradeca-4,6,10,12-tetraene, anti-syn stereoisomer) | EN0070 |
| anti-syn-[2.2](2,5)Thiazolophane (13,14-Dithia-5,12- diazatricyclo[8.2.1.1^(4,7)]tetradeca-4,6,10,12-tetraene, anti-syn stereoisomer) | EN0054 |
| anti-syn-[2.2](2,5)Thiazolophane-d4(13,14-Dithia-5,12-diazatricyclo[8.2.1.1^(4,7)]-tetradeca-4,6,10,12-tetraene-8,8,9,9-d4,anti-syn stereoisomer) | EN0056 |
| Aqueous Palladium Catalyst | EOX102 |
| Benz-Thy-Thy-H | EN0003 |
| Benz-Thy-Thy-Pim | EN0002 |
| Bicyclo[4.2.0]oct-(8)-ene-8-carbonitrile AROMP Polymer | ESB012 |
| Bicyclo[4.2.0]oct-(8)-ene-8-carboxylic acid AROMP Polymer | ESB011 |
| Bromomethyltriphenylphosphonium bromide | EN0050 |
| Chromone | EN0097 |
| Ethyl 2-bromo-3-oxo-propionate | EN0110 |
| H-Thy-Thy-Ems-OH | EN0004 |
| Hydroxymethylferrocene | EN0079 |
| Imidazole | EN0027 |
| O-Benzyl thymotic acid | EN0012 |
| Penteryrithritol tetratosylate | EN0010 |
| Phenacyl thymotate | EN0011 |
| Phthalimidomethyl Thymotate | EN0001 |
| poly(GMA-ran-OEGMA) Enzyme Stabilization Reagents | EGA697 |
| EGA698 | |
| Recombinant Microbial Laccase | FSA016 |
| FSA017 | |
| syn-syn-[2.2](2,5)Thiazolophane (13,14-Dithia-5,11- diazatricyclo[8.2.1.1^(4,7)]tetradeca-4,6,10,12-tetraene, syn-syn, syn-anti stereoisomer) | EN0057 |
| Terephthalaldehyde mono Ethylene Glycol Acetal | EN0032 |
| Description | Catalog No. |
| Violacein | FSA005 |
| FSA006 | |
| FSA007 |
| Description | Catalog No. |
| 4PD in vivo MDSC/Mφ Transfection Kit | EMI007 |
| Hepatocyte Culture Media | EMH007-LT |
| IDG-SW3 Bone Cell Line | EKC001 |
| EKC004 | |
| L6 Rat Myoblast Cell Line | ESK201-FP |
| L6-GLUT4myc Rat Myoblast Cell Line | ESK202-FP |
| LOBSTR E. coli Expression Strain | EC1002 |
| MHM – Hepatocyte Maintenance Medium | FCY042 |
| MHM3D – Hepatocyte 3D Culture Maintenance Medium | FCY051 |
| FCY052 | |
| FCY053 | |
| MHP – Hepatocyte Plating Medium | FCY039 |
| MHP3D – Hepatocyte 3D Culture Plating Medium | FCY048 |
| FCY049 | |
| FCY050 | |
| MHT – Hepatocyte Thawing Medium | FCY036 |
| MMMbz Blasticidin/Zeocin Resistant Cell Line | EF3004 |
| Mouse Macrophage Cell Line (AA9) for PRRSV Propagation | EWU001 |
| Murine Osteoblast to Osteocyte-like Cell Line MLO-A5 | EKC003 |
| Murine Osteocyte-like Cell Line MLO-Y4 | EKC002 |
| Nanodiamond Based DNA Delivery Reagent | ESA002 |
| Neuro-Dissociate Medium | EWA002 |
| EWA003 | |
| NPC Thawing Medium | FCY054 |
| Oral Epithelial HIV Cell Line | ECW001-FP |
| Oral Epithelial HIV Cell Line | ECW001-FP |
| Pancreatic Cell Differentiation Medium | ECH101 |
| ECH102 | |
| Perkinsus marinus (CB5D4) PmMOE-GFP | EMD101 |
| Residue-Free 3D Printed Cell Culture Inserts | ECU009 |
| ECU010 | |
| Retinal Muller Cell Line rMC-1 | ENW001 |
| RyR1 Expressing HEK293 Cell Line | EUR301 |
| Sf9 Easy Titer Cell Line (Sf-9 ET) | ENH022-FP |
| Trichoplusia ni Cell Line (Tni-FNL) | ENH127-FP |
| U-251 MG Glioblastoma Cell Line | EDK001 |
| Description | Catalog No. |
| Anti-TRA-1-60, IgG1 [Bstrongomab-9A] Antibody | FCM001 |
| Astrocyte LKB1 Knock Out Cell Line (ALKO) | EB9001-FP |
| hBM-MSC Elderly Donor | FEX003 |
| hBM-MSC Young, Healthy Donor | FEX001 |
| FEX002 | |
| hMSCs from adipose tissue (hADSCs) | FPM001 |
| hMSCs from endometrium (hEnMSCs) | FPM007 |
| hMSCs from placenta (hPSCs): from Amnion | FPM002 |
| hMSCs from placenta (hPSCs): from Chorion Villi | FPM004 |
| hMSCs from placenta (hPSCs): from Decidua | FPM003 |
| hMSCs from skin | FPM005 |
| hMSCs from umbilical cord (hUC-MSCs) | FPM006 |
| hUCAs-MSCs Human Umbilical Cord Arteries Mesenchymal Stem Cells | FPM008 |
| Human Mast Cell Line (LUVA) | EG1701-FP |
| MMMbz Blasticidin/Zeocin Resistant Cell Line | EF3004 |
| SACK-Xn 3C5 Adult Mouse Hair Follicle Stem Cells | EJS001 |
| SACK-Xs 12(3) Neonatal Human Liver Stem Cells | EJS002 |
| SACK-Xs Lig-13 Clonal Adult Rat Cholangiocytic Stem Cells | EJS004 |
| SACK-Xs Lig-8 Clonal Adult Rat Hepatocytic Stem Cells | EJS003 |
| Description | Catalog No. |
| Cryopreserved Human Hepatocyte (HuHEC) Cells | FCY001 |
| Cryopreserved Human Mixed Non-Parenchymal (HuNPC) Cells | FCY022 |
| Cryopreserved Human Stellate (HuSC) Cells | FCY024 |
| Cyropreserved Human Hepatocytes | EMH001-LT |
| Fresh Human Hepatocytes | EMH004-LT |
| Fresh Mouse Hepatocytes | EMH005 |
| Fresh Rat Hepatocytes | EMH006 |
| Hepatocyte Culture Media | EMH007-LT |
| MHM – Hepatocyte Maintenance Medium | FCY042 |
| MHM3D – Hepatocyte 3D Culture Maintenance Medium | FCY051 |
| FCY052 | |
| FCY053 | |
| MHP – Hepatocyte Plating Medium | FCY039 |
| MHP3D – Hepatocyte 3D Culture Plating Medium | FCY048 |
| FCY049 | |
| FCY050 | |
| MHT – Hepatocyte Thawing Medium | FCY036 |
| NPC Thawing Medium | FCY054 |
| NSCLC Patient Derived Xenograft (ADOR) | EVC004 |
| Rat Epineurial Cells | EMI012 |
| Rat Primary Schwann Cells | EMI010 |
| Description | Catalog No. |
| Canine Tumor Tissue Blocks | EMN022 |
| Description | Catalog No. |
| Dog (Mixed Breed) Tissue Samples | EGA685 |
| EGA696 | |
| EGA673 | |
| EGA674 | |
| EGA675 | |
| EGA676 | |
| EGA686 | |
| EGA687 | |
| EGA688 | |
| EGA689 | |
| EGA690 | |
| EGA691 | |
| EGA692 | |
| EGA693 | |
| EGA694 | |
| EGA695 | |
| EGA677 | |
| EGA678 | |
| EGA679 | |
| EGA680 | |
| EGA681 | |
| EGA682 | |
| EGA683 | |
| EGA684 |
| Description | Catalog No. |
| Mouse (C57BL/6) Tissue Samples | EGA609 |
| EGA610 | |
| EGA611 | |
| EGA674 | |
| EGA612 | |
| EGA613 | |
| EGA614 | |
| EGA615 | |
| EGA616 | |
| EGA617 | |
| EGA618 | |
| EGA619 | |
| EGA620 | |
| EGA621 | |
| EGA622 | |
| EGA623 | |
| EGA624 | |
| EGA601 | |
| EGA602 | |
| EGA603 | |
| EGA604 | |
| EGA605 | |
| EGA606 | |
| EGA607 | |
| EGA608 |
| Description | Catalog No. |
| Mouse (FVB/N) Tissue Samples | EGA645 |
| EGA646 | |
| EGA625 | |
| EGA626 | |
| EGA627 | |
| EGA647 | |
| EGA648 | |
| EGA628 | |
| EGA629 | |
| EGA630 | |
| EGA631 | |
| EGA632 | |
| EGA633 | |
| EGA634 | |
| EGA635 | |
| EGA636 | |
| EGA637 | |
| EGA638 | |
| EGA639 | |
| EGA640 | |
| EGA641 | |
| EGA642 | |
| EGA643 | |
| EGA644 |
| Description | Catalog No. |
| NSCLC Patient Derived Xenograft (ADOR) | EVC004 |
| Description | Catalog No. |
| Rat (Sprague-Dawley) Tissue Samples | EGA662 |
| EGA663 | |
| EGA664 | |
| EGA665 | |
| EGA666 | |
| EGA649 | |
| EGA650 | |
| EGA651 | |
| EGA652 | |
| EGA653 | |
| EGA654 | |
| EGA655 | |
| EGA656 | |
| EGA657 | |
| EGA667 | |
| EGA668 | |
| EGA669 | |
| EGA670 | |
| EGA671 | |
| EGA672 | |
| EGA658 | |
| EGA659 | |
| EGA660 | |
| EGA661 |
| Description | Catalog No. |
| Tissue Preservation Chamber | FSW001 |
| Description | Catalog No. |
| Versatool Kit for Cryosectioning | FEI001 |
| Description | Catalog No. |
| Baculovirus AcMNPV Expressing E. coli Cell Line (DE35) | ENH072-FP |
| BAP1 E. coli Strain | ESU002 |
| E. coli Strain ALS1038 | EGA509 |
| E. coli Strain ALS1048 | EGA510 |
| E. coli Strain ALS1054 | EGA503 |
| E. coli Strain ALS1058 | EGA504 |
| E. coli Strain ALS1059 | EGA505 |
| E. coli Strain ALS1060 | EGA511 |
| E. coli Strain ALS1073 | EGA512 |
| E. coli Strain ALS1074 | EGA513 |
| E. coli Strain ALS1122 | EGA515 |
| E. coli Strain ALS1370 | EGA514 |
| E. coli Strain ALS1371 | EGA506 |
| E. coli Strain ALS1391 | EGA507 |
| E. coli Strain ALS1392 | EGA508 |
| E. coli Strain ALS929 | EGA501 |
| E. coli Strain ALS974 | EGA502 |
| E. coli Strain BLT7Bio | EMI009 |
| E. coli Strain BLT7FLAG | EMI008 |
| LOBSTR E. coli Expression Strain | EC1002 |
| Description | Catalog No. |
| pCAG-Gal4DBD-GBP2 Plasmid | EF1003 |
| pCAG-GBP1-10gly-Gal4DBD Plasmid | EF1004 |
| pCAG-GBP7-p65AD Plasmid | EF1001 |
| pCAG-p65AD-GBP6 Plasmid | EF1002 |
| pNCA-C-SNH Moloney Murine Leukemia Virus (M-MuLV) Plasmid | ED6002 |
| Description | Catalog No. |
| 6dEB Plasmids | ESU003 |
| ESU004 | |
| Anti-SARS-CoV-2 Nucleocapsid Protein [mBG17] Antibody Expression Plasmids | ECS011 |
| ECS012 | |
| Anti-SARS-CoV-2 Nucleocapsid Protein [mBG86] Antibody Expression Plasmids | ECS013 |
| ECS014 | |
| CD44CR1-GFP Reporter Plasmid | ED4002 |
| C-DAG Amyloidogenicity Kit | EF2001 |
| EF2002 | |
| EF2003 | |
| EF2004 | |
| eGFP Expressing Lentivirus Vectors | ENH045-FP |
| ENH046-FP | |
| ENH047-FP | |
| ENH048-FP | |
| ENH049-FP | |
| ENH050-FP | |
| ENH051-FP | |
| ENH038-FP | |
| ENH039-FP | |
| ENH040-FP | |
| ENH041-FP | |
| ENH042-FP | |
| ENH043-FP | |
| ENH044-FP | |
| EGFP-COSMO Plasmids | EUT502 |
| EUT503 | |
| EUT504 | |
| Erythromycin A Production Plasmids | ETU006 |
| ETU007 | |
| ffLuc2-eGFP Expressing Lentivirus Vectors | ENH064-FP |
| ENH065-FP | |
| ENH052-FP | |
| ENH053-FP | |
| ENH054-FP | |
| ENH055-FP | |
| ENH056-FP | |
| ENH057-FP | |
| ENH058-FP | |
| ENH059-FP | |
| ENH060-FP | |
| ENH061-FP | |
| ENH062-FP | |
| ENH063-FP | |
| FLAG-Frankenbody Expression Plasmids | ECS019 |
| ECS020 | |
| Foxn4CR4.2-GFP Reporter Plasmid | ED4001 |
| GAD65 (Syn1) pFSW67 Lentivirus Plasmid | ECS022 |
| GAD67 (Syn1) pFSW67 Lentivirus Plasmid | ECS023 |
| GFP-Caffebody Plasmid | EUT507 |
| GFP-Sunbody Plasmids | EUT505 |
| EUT506 | |
| HA Frankenbody Expression Plasmids | ECS015 |
| ECS016 | |
| ECS017 | |
| Human Bcl-xL Plasmids | EUL007 |
| EUL008 | |
| EUL009 | |
| EUL010 | |
| IFITM3-EGFP Expression Plasmid | ES2003 |
| IFITM3-NG Expression Plasmid | ES2004 |
| IFITM3-TFP1 Expression Plasmid | ES2005 |
| KRAS4b Baculovirus Expression Vectors | ENH113-FP |
| ENH114-FP | |
| ENH107-FP | |
| ENH099-FP | |
| ENH108-FP | |
| ENH109-FP | |
| ENH110-FP | |
| ENH111-FP | |
| ENH112-FP | |
| Marker-Free Transgenic Plant Vectors | EAK001 |
| EAK002 | |
| mCh-Moonbody Plasmid | EUT509 |
| Notch1CR2-GFP Reporter Plasmid | ED4003 |
| pA-B(D1080A)-CD RecBCD Expression Plasmid | EMD003 |
| pBG167 Recombinant Sindbis Virus Expression Plasmid | ECS006 |
| pBG167 Recombinant Sindbis Virus Expression Plasmid | ECS006 |
| pBG210 Recombinant Sindbis Virus Expression Plasmid – Gateway Compatible | ECS007 |
| pBG218 Recombinant Sindbis Virus-GFP Expression Plasmid | ECS008 |
| pBG256 Recombinant Sindbis Virus Replicon Packaging Plasmid | ECS009 |
| pBG60 Recombinant Sindbis Replicon Expression Plasmid – Gateway Compatible | ECS003 |
| pBG68 Recombinant Sindbis Virus Replicon Expression Plasmid | ECS004 |
| pBG690 SARS-CoV-2 Nucleocapsid Protein Expression Plasmid | ECS010 |
| pBG78 Recombinant Sindbis Virus Replicon Plasmid – GFP Expressing | ECS005 |
| pBS-G-ФT Plasmid | EH1016 |
| pBS-L-ФT Plasmid | EH1015 |
| pBS-N-ФT Plasmid | EH1013 |
| pBS-P-ФT Plasmid | EH1014 |
| pBSSK-Gpr177 in situ Hybridization Plasmid | EUR304 |
| pC3C Phage Display Plasmids | ENH067-FP |
| ENH068-FP | |
| pCAG-Gal4DBD-GBP2 Plasmid | EF1003 |
| pCAG-GBP1-10gly-Gal4DBD Plasmid | EF1004 |
| pCAG-GBP7-p65AD Plasmid | EF1001 |
| pCAGGS-G-Kan Plasmid | EH1017 |
| pCAG-p65AD-GBP6 Plasmid | EF1002 |
| pcDNA-3FHP Hepatitis B Virus (HBV) Polymerase Protein Expression Plasmid | EQ0006 |
| pCMV-HE Hepatitis B Virus (HBV) Epsilon RNA Expression Plasmid | EQ0007 |
| pCORE Plasmid | ENH158-FP |
| pCORE-Hp53 Plasmid | ENH162-FP |
| pCORE-Kp53 Plasmid | ENH161-FP |
| pCORE-UH Plasmid | ENH160-FP |
| pCORE-UK Plasmid | ENH159-FP |
| pCS2-Gpr177 Expression Plasmid | EUR305 |
| pCS2-SENP2(L) Plasmid | EUR306 |
| pCS2-SENP2(L)Neo Plasmid | EUR307 |
| pCS2-SENP2(M) Plasmid | EUR308 |
| pCS2-SENP2(M)Neo Plasmid | EUR309 |
| pCS2-SENP2(S) Plasmid | EUR310 |
| pCS2-SENP2(S)Neo Plasmid | EUR311 |
| pET 21d.1 VSV-M (M51R) plasmid | EB0002 |
| pET 21d.1 VSV-M plasmid | EB0001 |
| pFA6A-GFP-ura4MX6 Plasmid | EDX001 |
| pGEM-Gpr177 in situ Hybridization Plasmid | EUR303 |
| pGEX-5X-1-Znf131 Plasmids | EMC004 |
| EMC003 | |
| EMC005 | |
| EMC006 | |
| EMC007 | |
| pGL3-Gpr177_1 Plasmid | EUR312 |
| pGL3-Gpr177_2 Luciferase Plasmid | EUR313 |
| pGL3-Gpr177_3 Plasmid | EUR314 |
| pGL3-Gpr177_4 Plasmid | EUR315 |
| pGLuc-TATA KBS/ZBE Plasmids | EMC002 |
| EMC001 | |
| pGSHU Plasmid | ENH163-FP |
| pGSKU Plasmid | ENH157-FP |
| pHHyDHODH-GFP Expression Plasmid | EDX007 |
| pLU-CMV-GFP-pBLAST Lentiviral Plasmid | EWI034 |
| pLU-JARID1B promoter-EGFP Lentiviral Plasmid | EWI024-FP |
| pMeca Plasmid | EGA310 |
| pMocr (6xHis-Mocr tag) Plasmid | EMU010 |
| pNCA-C-SNH Moloney Murine Leukemia Virus (M-MuLV) Plasmid | ED6002 |
| Human Bcl-xL Plasmids | EUL007 |
| EUL008 | |
| EUL009 | |
| EUL010 | |
| pSD VSV-M plasmid | EB0003 |
| pSVJ21 Psychrophilic Bacterium Shuttle Vector | EQ2001 |
| pVSV-Δ-G-CHIKV-E_nLucP Plasmid | EGA294 |
| pVSV-Δ-G-EBOV-GP_nLucP Plasmid | EGA291 |
| pVSV-Δ-G-LASV-GP_nLucP Plasmid | EGA293 |
| pVSV-Δ-G-SARS-CoV-2-S_nLucP Plasmid | EGA292 |
| pVSV-Δ-G-VSV-G_nLucP Plasmid | EGA295 |
| Serratia marcescens DNA/RNA Nonspecific Nuclease Expression Plasmid | EVC009 |
| Set of Helper Plasmids (VSV-N, VSV-P, VSV-L, VSV-G) | EH1012 |
| Stable RAP Expression Plasmid | EMD008 |
| Translation and Tethering (TnT) Plasmid | ECS018 |
| Trypanosoma cruzi CRISPR/Cas9 System | EGA031 |
| EGA032 | |
| EGA033 | |
| vGAT (Syn1) pFSW67 Lentivirus Plasmid | ECS021 |
| VSV-FL+(2) VSV Plasmid Expression Vector | EH1001 |
| VSV-ΔG-DsRed Plasmid Expression Vector | EH1005 |
| EH1006 | |
| VSV-ΔG-GFP Plasmid Expression Vector | EH1003 |
| EH1004 | |
| VSV-ΔG-GFP-2.6 Plasmid Expression Vector | EH1026 |
| EH1027 | |
| VSV-ΔG-Luciferase Plasmid Expression Vector | EH1007 |
| EH1008 | |
| VSV-ΔG-N/P-MCS2-2.6 Plasmid Expression Vector | EH1028 |
| EH1029 | |
| VSV-ΔG-P/M-MCS2-2.6 Plasmid Expression Vector | EH1032 |
| EH1033 | |
| VSV-ΔG-PL 2.5 Plasmid Expression Vector | EH1030 |
| EH1031 | |
| VSV-ΔL-GFP Plasmid Expression Vector | EH1009 |
| EH1010 | |
| Zika Virus Plasmids | ECS001 |
| ECS002 |
| Description | Catalog No. |
| ArborEasy® DNA Isolation Kit | EIF001 |
| Azide-PEG3-Maleimide kit | FCC080 |
| FCC081 | |
| BioUltra SARS-CoV-2 Nucleocapsid ELISA Kit | FAT002 |
| BioUltra SARS-CoV-2 Spike Protein ELISA Kit | FAT003 |
| Button Tether for Rat Infusions | EH3001 |
| C-DAG Amyloidogenicity Kit | EF2001 |
| EF2002 | |
| EF2003 | |
| EF2004 | |
| GST-PAK-CRIB Rac/Cdc42 Isolation Kit | EOS001 |
| IgG Quantification ABC Kit (human-specific) | ABCK0002 |
| IgG Quantification ABC Kit (pan-specific) | ABCK0001 |
| KAZU DNA Extraction Buffer | EDD001 |
| EDD002 | |
| EDD003 | |
| Lys-to-Lys Protein-Protein Conjugation Kit | FCC595 |
| MarathonRT Reverse Transcriptase | EYU007 |
| EYU008-FP | |
| Microplate Loading Platform | ESC001 |
| MSTI Fluorescence-Based Thiol-Reactive Assay | EWM001 |
| Optimized ECL Reagent | ESL201 |
| Protein Buffers for Mass Spectrometric Immunoassay (MSIA) | EAS002 |
| EAS003 | |
| EAS001 | |
| Protein Click Reaction Buffer Kit | FCC367 |
| Protein-Nucleic Acid Complex Crystal Screen | EE0001 |
| Ready-to-Use and Load PCR Master Mix | EWS003 |
| EWS004 | |
| EWS005 | |
| Residue-Free 3D Printed Cell Culture Inserts | ECU009 |
| ECU010 | |
| Slide-In Plant Chamber | EH4001 |
| Tissue Preservation Chamber | FSW001 |
| Versatool Kit for Cryosectioning | FEI001 |
We offer novel in vitro and in vivo probes for cysteine sulfenic acid formation in proteins resulting from the oxidative modification of susceptible cysteine residues by mild oxidizing agents such as hydrogen peroxide, alkyl hydroperoxides, and peroxynitrite. These modifications are of considerable biological interest as important players in redox catalysis and redox regulation, yet they have been notoriously difficult to identify due to their high reactivity, particularly outside their native protein environments.
| Description | Catalog No. |
| Biotin-1,3-cyclopentanedione (BP1) | EE1004 |
| EE1005 | |
| EE1006 | |
| DCP-Bio1 | EE0028 |
| Norbornene-PEG-Biotin (Norb-Bio) Probe | EFL008 |
| DCP-Rho1 | EE0031 |
| DCP-Alkyne | EE0032 |
| EE0033 | |
| DYn-2 Sulfenic Acid Probe | EST018 |
| EST019 | |
| EST020 | |
| EST021 | |
| DYn-2-d6 Sulfenic Acid Probe | EST008 |
| EST009 | |
| EST006 | |
| EST007 | |
| NO-Bio Sulfinic Acid Probe | EST011 |
| EST012 | |
| EST013 | |
| DCP-N3 | EE0026 |
| NAPhAz-1 | EST001 |
| EST002 | |
| EST003 | |
| BiPhAz-1 | EST005 |
| EST010 | |
| EST004 | |
| Anti-Cysteine Sulfenic Acid (2-Thiodimedone) Antibody | EST022 |
| CN-Alkyne | EST025 |
| EST026 | |
| EST027 | |
| EST028 | |
| NO2-Alkyne | EST029 |
| EST030 | |
| EST031 | |
| EST032 | |
| Anti-PTP-S-Dimedone Antibody | EST023 |
| EST024 | |
| Dimedone-d6 | EST014 |
| EST015 | |
| EST016 | |
| EST017 | |
| Free Methionine-(R)-Sulfoxide Reductase (fRMsr), (C84S, C94S) | EE2001 |
| EE2002 | |
| Biotinylated-Trx Loading Control Protein | EE0034 |
| EE0035 | |
| Protein Buffers for Mass Spectrometric Immunoassay (MSIA) | EAS002 |
| EAS003 | |
| EAS001 | |
| MSTI Fluorescence-Based Thiol-Reactive Assay | EWM001 |
| Description | Catalog No. |
| 13C6-UV Cleavable Biotin-Azide | EVU151 |
| Alkyne-PEG4-Biotin Conjugate | FCC125 |
| Anti-IgG-Biotin, Marmoset Pan-Species [2B11-Biotin] Antibody | ET0008 |
| Biotin-1,3-cyclopentanedione (BP1) | EE1004 |
| EE1005 | |
| EE1006 | |
| Biotin-Alkyne | EVU103 |
| Biotin-Azide | EVU101 |
| Biotin-PEG3-Azide | FCC083 |
| FCC084 | |
| Biotin-PEG4-NHS Ester | FCC172 |
| FCC173 | |
| Biotinylated Polyphosphate, Long Chain (p700) | EUI006 |
| Biotinylated sRNA Ladder | EGA701 |
| Biotinylated-Trx Loading Control Protein | EE0034 |
| EE0035 | |
| Broad Range DNA Ladder | ESA115 |
| DBCO-Diazo Biotin | FCC372 |
| DBCO-PEG4-Biotin | FCC038 |
| FCC039 | |
| DBCO-PEG4-Desthiobiotin | FCC323 |
| FCC324 | |
| Desthiobiotin-PEG3-Azide | FCC337 |
| FCC338 | |
| Desthiobiotin-PEG4-Alkyne | FCC359 |
| FCC360 | |
| Diazo Biotin-Alkyne | FCC357 |
| Diazo Biotin-Azide | FCC330 |
| Engineered Monomeric Streptavidin 2 (mSA2) Protein | EBU001 |
| EBU002 | |
| Streptavidin Mutein Matrix SAVSBPM18 | EUC012 |
| TAMRA-Azide-Biotin | FCC332 |
| FCC333 | |
| TAMRA-Azide-Desthiobiotin | FCC334 |
| FCC335 | |
| UV Cleavable Biotin-Alkyne | EVU104 |
| UV Cleavable Biotin-Azide | EVU102 |
| Description | Catalog No. |
| Alkyne-PEG4-NHS Ester | FCC118 |
| FCC119 | |
| Azide-PEG4-NHS Ester | FCC077 |
| FCC078 | |
| Azidoacetic Acid NHS Ester | FCC325 |
| FCC326 | |
| Azidobutyric acid NHS ester | FLP001 |
| FLP002 | |
| FLP003 | |
| BDP FL NHS ester | FLP273 |
| FLP274 | |
| FLP275 | |
| FLP276 | |
| FLP277 | |
| BDP R6G NHS ester | FLP283 |
| FLP284 | |
| FLP285 | |
| FLP286 | |
| FLP287 | |
| BDP TMR NHS ester | FLP319 |
| FLP315 | |
| FLP316 | |
| FLP317 | |
| FLP318 | |
| BDP TR methyl ester | FLP320 |
| BDP TR NHS ester | FLP321 |
| FLP322 | |
| FLP323 | |
| FLP324 | |
| FLP325 | |
| Biotin-NHS Ester | FCC461 |
| FCC462 | |
| Biotin-PEG4-NHS Ester | FCC172 |
| FCC173 | |
| Bis-sulfone NHS Ester | FCC378 |
| FCC379 | |
| Coumarin 343 X NHS ester | FLP336 |
| FLP337 | |
| FLP338 | |
| FLP339 | |
| FLP340 | |
| Cy2 NHS ester minimal dye | FLP341 |
| FLP342 | |
| FLP343 | |
| Cy3 NHS ester | FLP124 |
| FLP125 | |
| FLP126 | |
| FLP127 | |
| FLP128 | |
| Cy3 NHS ester minimal dye | FLP354 |
| FLP355 | |
| FLP356 | |
| Cy3.5 NHS ester | FLP129 |
| FLP130 | |
| FLP131 | |
| Cy5 NHS ester minimal dye | FLP378 |
| FLP379 | |
| FLP380 | |
| Cy7 NHS ester | FLP142 |
| FLP143 | |
| FLP144 | |
| FLP145 | |
| FLP146 | |
| Cy7.5 NHS ester | FLP151 |
| FLP147 | |
| FLP148 | |
| FLP149 | |
| FLP150 | |
| Cyanine5 NHS ester | FLP132 |
| FLP133 | |
| FLP134 | |
| FLP135 | |
| FLP136 | |
| Cyanine5.5 NHS ester | FLP137 |
| FLP138 | |
| FLP139 | |
| FLP140 | |
| FLP141 | |
| DBCO-C6-NHS Ester | FCC304 |
| FCC305 | |
| DBCO-NHS ester | FCC008 |
| FCC009 | |
| FCC010 | |
| DBCO-PEG4-NHS ester | FCC011 |
| FCC012 | |
| FCC013 | |
| FCC014 | |
| DBCO-PEG5-NHS Ester | FCC306 |
| FCC307 | |
| FCC308 | |
| FCC309 | |
| FCC310 | |
| Methyltetrazine-PEG4-NHS Ester | FCC204 |
| FCC205 | |
| FCC206 | |
| FCC207 | |
| Pentynoic acid STP ester | FLP097 |
| Propargyl-NHS ester | FCC138 |
| FCC139 | |
| Pyrenebutyric acid NHS ester | FLP487 |
| ROX NHS ester, pure 6- isomer | FLP152 |
| FLP153 | |
| FLP154 | |
| FLP155 | |
| Sulfo-Cy3 NHS ester | FLP109 |
| FLP110 | |
| FLP111 | |
| FLP112 | |
| FLP113 | |
| Sulfo-Cy5 NHS ester | FLP114 |
| FLP115 | |
| FLP116 | |
| FLP117 | |
| FLP118 | |
| Sulfo-Cy5.5 NHS ester | FLP568 |
| FLP569 | |
| FLP570 | |
| FLP571 | |
| FLP572 | |
| Sulfo-Cy7 NHS ester | FLP119 |
| FLP120 | |
| FLP121 | |
| FLP122 | |
| FLP123 | |
| TCO-NHS ester | FCC195 |
| FCC196 | |
| FCC197 | |
| TCO-PEG4-NHS ester | FCC184 |
| FCC185 | |
| FCC186 | |
| FCC187 | |
| Z-Cy2 NHS Ester | EMT001 |
| Z-Cy2 NHS Ester | EMT001 |
| Z-Cy3 NHS Ester | EMT002 |
| Z-Cy5 NHS Ester | EMT003 |
| Description | Catalog No. |
| Alkyne-PEG4-Maleimide | FCC121 |
| FCC122 | |
| Azide-PEG3-Maleimide kit | FCC080 |
| FCC081 | |
| BDP FL maleimide | FLP268 |
| FLP269 | |
| FLP270 | |
| FLP271 | |
| FLP272 | |
| BDP TMR maleimide | FLP310 |
| FLP311 | |
| FLP312 | |
| FLP313 | |
| FLP314 | |
| Biotin-PEG3-Maleimide | FCC516 |
| FCC517 | |
| FCC518 | |
| Cy3 - maleimide | FLP163 |
| FLP164 | |
| FLP165 | |
| FLP166 | |
| Cy5 Maleimide | FCC557 |
| FCC558 | |
| FCC559 | |
| FCC560 | |
| Cy5 Maleimide, 5 x 0.5 mg | FCC556 |
| Cy5.5 Maleimide | FCC580 |
| FCC581 | |
| FCC582 | |
| FCC583 | |
| Cy5-Maleimide | FLP169 |
| FLP170 | |
| FLP167 | |
| FLP168 | |
| Cy7.5 maleimide | FLP424 |
| FLP425 | |
| FLP426 | |
| FLP427 | |
| FLP423 | |
| Cyanine5.5 maleimide | FLP171 |
| FLP172 | |
| FLP173 | |
| DBCO-Maleimide | FCC022 |
| FCC023 | |
| FCC024 | |
| DBCO-PEG4-Maleimide | FCC026 |
| FCC027 | |
| FCC028 | |
| FCC025 | |
| FAM maleimide, 6-isomer | FLP452 |
| FLP453 | |
| FLP454 | |
| Methyltetrazine-PEG4-Maleimide | FCC209 |
| FCC210 | |
| FCC211 | |
| Propargyl-Maleimide | FCC152 |
| FCC153 | |
| Pyrene maleimide | FLP478 |
| FLP479 | |
| FLP480 | |
| FLP481 | |
| FLP482 | |
| Sulfo-Cy3 maleimide | FLP515 |
| FLP516 | |
| FLP517 | |
| FLP518 | |
| FLP519 | |
| Sulfo-Cy5 maleimide | FLP536 |
| FLP537 | |
| FLP538 | |
| FLP539 | |
| FLP540 | |
| Sulfo-Cy7 maleimide | FLP595 |
| FLP596 | |
| FLP597 | |
| FLP598 | |
| FLP599 | |
| TCO-PEG3-Maleimide | FCC188 |
| FCC189 | |
| FCC190 | |
| FCC191 | |
| Z-Cy2 Maleimide | EMT004 |
| Z-Cy3 Maleimide | EMT005 |
| Z-Cy5 Maleimide | EMT006 |
| Description | Catalog No. |
| Alkyne-PEG4-Acid | FCC115 |
| FCC116 | |
| Alkynyl Arachidonic Acid | EVU113 |
| Alkynyl Linoleic Acid | EVU112 |
| Alkynyl Oleic Acid | EVU107 |
| Alkynyl Palmitic Acid | EVU105 |
| Alkynyl Stearic Acid | EVU106 |
| Azide-PEG4-Acid | FCC074 |
| FCC075 | |
| BDP 630/650 carboxylic acid | FLP237 |
| FLP238 | |
| FLP239 | |
| FLP240 | |
| FLP241 | |
| BDP FL carboxylic acid | FLP258 |
| FLP259 | |
| FLP260 | |
| FLP261 | |
| FLP262 | |
| BDP R6G carboxylic acid | FLP278 |
| FLP279 | |
| FLP280 | |
| FLP281 | |
| FLP282 | |
| BDP TMR carboxylic acid | FLP308 |
| FLP309 | |
| FLP305 | |
| FLP306 | |
| FLP307 | |
| Bis-sulfone Acid | FCC374 |
| FCC375 | |
| Coumarin 343 X carboxylic acid | FLP331 |
| FLP332 | |
| FLP333 | |
| FLP334 | |
| FLP335 | |
| Cy3 carboxylic acid | FLP175 |
| FLP176 | |
| FLP177 | |
| FLP178 | |
| Cy3.5 carboxylic acid | FLP362 |
| FLP363 | |
| FLP364 | |
| FLP365 | |
| FLP366 | |
| Cy5 carboxylic acid | FLP179 |
| FLP180 | |
| FLP181 | |
| FLP182 | |
| FLP183 | |
| Cy5.5 carboxylic acid | FLP184 |
| FLP185 | |
| FLP186 | |
| FLP187 | |
| Cy7 carboxylic acid | FLP188 |
| FLP189 | |
| FLP190 | |
| FLP191 | |
| FLP192 | |
| Cy7.5 carboxylic acid | FLP193 |
| FLP194 | |
| FLP195 | |
| FLP196 | |
| FLP197 | |
| DBCO-Acid | FCC312 |
| FCC313 | |
| DBCO-PEG5-Acid | FCC301 |
| FCC302 | |
| FCC303 | |
| Sulfo-Cy3 carboxylic acid | FLP510 |
| FLP511 | |
| FLP512 | |
| FLP513 | |
| FLP514 | |
| Sulfo-Cy5 carboxylic acid | FLP174 |
| Sulfo-Cy5.5 carboxylic acid | FLP565 |
| FLP565 | |
| FLP566 | |
| FLP567 | |
| FLP563 | |
| Sulfo-Cy7 carboxylic acid | FLP590 |
| FLP591 | |
| FLP592 | |
| FLP593 | |
| FLP594 | |
| Sulfo-Cy7.5 carboxylic acid | FLP603 |
| FLP604 | |
| FLP600 | |
| FLP601 | |
| FLP602 |
| Description | Catalog No. |
| Neutrophil Specific, NIR Fluorescent Imaging Agent | EG0001 |
| Neutrophil Specific, PET Imaging Agent | EG0046 |
| Semkur-IM | FVM001 |
| Description | Catalog No. |
| BioGraphene Gr-SA | ECN023 |
| CAN-Fe2O3 Nanoparticles | EBI002 |
| GlowDot10 Protein-Based Fluorescent Nanoparticles | ECN017 |
| ECN018 | |
| ECN019 | |
| ECN020 | |
| ECN021 | |
| ECN022 | |
| GlowDot40 Protein-Based Fluorescent Nanoparticles | ECN003 |
| ECN004 | |
| ECN005 | |
| ECN006 | |
| ECN007 | |
| ECN008 | |
| ECN016 | |
| ECN009 | |
| ECN010 | |
| ECN011 | |
| Hybrid PEI25/Al-CAN-Fe2O3 Nanoparticles | EBI006 |
| Hybrid PEI25/HA15-30-CAN-Fe2O3 Nanoparticles | EBI005 |
| Nanoparticle Generation Services | ETV005 |
| Oxidized PEI25-CAN-Fe2O3 Nanoparticles | EBI004 |
| PCzBT and PCzDTBT Polymer Nanoparticles (Pdots) | EKA002 |
| EKA003 | |
| PEI25-CAN-Fe2O3 Nanoparticles | EBI003 |
| Poly(dithiazolfluorene-alt-thiadiazolobenzotriazole) (PSN) Nanoparticles | EKA001 |
| TEV HALO Magnetic Nanoparticles | ECU017 |
| Description | Catalog No. |
| Biotinylated sRNA Ladder | EGA701 |
| Broad Range DNA Ladder | ESA115 |
| KAZU DNA Extraction Buffer 1mL (Trial Size) | EDD001 |
| KAZU DNA Extraction Buffer 10mL (100 rxns) | EDD002 |
| KAZU DNA Extraction Buffer 50mL (500 rxns) | EDD003 |
| Lyophilized Ready-to-Use and Load PCR Master Mix Master Mix 25 rxns | EWS001 |
| Lyophilized Ready-to-Use and Load PCR Master Mix Master Mix 4x 25rxns | EWS002 |
| Microplate Loading Platform | ESC001 |
| Non-Natural Promoter T7 Polymerase | EUT001 |
| Ready-to-Use and Load PCR Master Mix 50 rxns | EWS003 |
| Ready-to-Use and Load PCR Master Mix 5×50 rxns | EWS004 |
| Ready-to-Use and Load PCR Master Mix 10×50 rxns | EWS005 |
| Description | Catalog No. |
| 13C,15N-Murine Myelin Basic Protein C1 Isoform, 1-105 (MBP 13C,15N-DC-rmMBP) | EGP011 |
| 13C,15N-Murine Myelin Basic Protein, S72-S107, Immuno-Dominant Epitope (MBP-13C,15N-a2-peptide) | EGP002 |
| 4-(5-dimethylamino-phenyl-2-oxazolyl) benzenesulfonamide | KPG001 |
| Alpha-Crystallin Homolog (Mb sHSP) Hexadecamer Protein | EMD005 |
| Anti-Heteromannan [LM22] Antibody | ELD035 |
| Anti-Pectic Polysaccharide (Branched Galactan) [LM26] Antibody | ELD036 |
| Anti-Xylosyl Residues [LM23] Antibody | ELD037 |
| B6/129 Macrophage Cell Line | ENH164-FP |
| Biotinylated-Trx Loading Control Protein 50ug (1mg/mL) | EE0034 |
| Biotinylated-Trx Loading Control Protein 250ug (1mg/mL) | EE0035 |
| C57BL/10SnJ (B10) Macrophage Cell Line | ENH165-FP |
| Classical Swine Fever Virus E2 glycoporotein, rCSFE2-1 100ug | FGN028 |
| Classical Swine Fever Virus E2 glycoporotein, rCSFE2-1 500ug | FGN029 |
| Classical Swine Fever Virus E2 glycoporotein, rCSFE2-1 1mg | FGN030 |
| Complement C1s Enzyme | ETL001 |
| Complement C1s Proenzyme | ETL002 |
| Cry1Ac toxin, RBT001 100ug | FGN037 |
| Cry1Ac toxin, RBT001 500ug | FGN038 |
| Cry1F toxin, RBT002 100ug | FGN040 |
| Cry1F toxin, RBT002 500ug | FGN041 |
| Cry1F toxin, RBT002 1mg | FGN042 |
| E117A-apoCA-tagRFP Biosensor Protein | KPG008 |
| EF K313R (Anthrax Edema Factor Mutant (EF-A K313R)) | ENH014-LT |
| Engineered Monomeric Streptavidin 2 (mSA2) Protein 1mg | EBU001 |
| Engineered Monomeric Streptavidin 2 (mSA2) Protein 3mg | EBU002 |
| EPSPS protein, REPSPS1 100ug | FGN055 |
| EPSPS protein, REPSPS1 500ug | FGN056 |
| EPSPS protein, REPSPS1 1mg | FGN057 |
| Ferredoxin [4Fe-4S] | EGA302 |
| Fluorescent U-tag SUMO Trapping Protein (KmUTAG-fl) | EWM103 |
| FP59 (Anthrax Lethal Factor Fusion to Pseudomonas Exotoxin A Catalytic Domain (FP59-AGG)) | ENH013-LT |
| GST-PAK-CRIB Rac/Cdc42 Isolation Kit | EOS001 |
| H94N-apoCA-tagRFP Biosensor Protein | KPG007 |
| Heat-Labile Enterotoxin (HLT) LT-IIa | EBU028 |
| Heat-Labile Enterotoxin (HLT) LT-IIb | EBU029 |
| Heat-Labile Enterotoxin (HLT) LT-IIc | EBU030 |
| Histone H4 (N-term 6xHis-tag, human recombinant) | FS0004 |
| Human CD32, rhFCY01 100ug | FGN010 |
| Human CD32, rhFCY01 500ug | FGN011 |
| Human CD32, rhFCY01 1mg | FGN012 |
| Human Dipeptidase (PEPD) Inactive (G278D) Protein | EVC013 |
| Human Dipeptidase (PEPD) Protein | EVC012 |
| Human GM2 Ganglioside | ESK002 |
| Human IL6 Protein, RIL001 100ug | FGN004 |
| Human IL6 Protein, RIL001 500ug | FGN005 |
| Human IL6 Protein, RIL001 1mg | FGN006 |
| Human IL6 Receptor, RIL002 100ug | FGN007 |
| Human IL6 Receptor, RIL002 500ug | FGN008 |
| Human IL6 Receptor, RIL002 1mg | FGN009 |
| Human Laminin 332 | EUV102 |
| Human Lc3B-6His (LC3B) | EGP001 |
| Human Norrin Protein | EW0007 |
| Human S100A8/A9 Heterodimer (Calprotectin) 50ug, 12.2mg/mL | EVU201 |
| Human S100A8/A9 Heterodimer (Calprotectin) 500ug, 8.3mg/mL (Endotoxin-Free) | EVU204 |
| Human S100A8/A9 Heterodimer (Calprotectin) 500ug, 12.2mg/mL | EVU203 |
| Human S100A8/A9 Heterodimer (Calprotectin) 50ug, 8.3mg/mL (Endotoxin-Free) | EVU202 |
| Human STAT3, rSTAT3-14 Kda 100ug | FGN025 |
| Human STAT3, rSTAT3-14 Kda 500ug | FGN026 |
| Human STAT3, rSTAT3-14 Kda 1mg | FGN027 |
| Human STAT3, rSTAT3-63 100ug | FGN019 |
| Human STAT3, rSTAT3-63 500ug | FGN020 |
| Human STAT3, rSTAT3-63 1mg | FGN021 |
| Human STAT3, rSTAT3-80 100ug | FGN016 |
| Human STAT3, rSTAT3-80 500ug | FGN017 |
| Human STAT3, rSTAT3-80 1mg | FGN018 |
| Human TNF alpha, RTNF001 100ug | FGN001 |
| Human TNF alpha, RTNF001 500ug | FGN002 |
| Human TNF alpha, RTNF001 1mg | FGN003 |
| Human Vitronectin N-GST (full-length) | EUR121 |
| Human α-Synuclein, A53T Variant (α-syn-A53T) | EGP013 |
| Human α-Synuclein, E46K Variant (α-syn-E46K) | EGP015 |
| Human α-Synuclein, WT (α-syn-WT) | EGP017 |
| Hyperphosphorylated Microtubule-Associated Protein Tau (MAPT) | ESP101 |
| Hyperstable Hsp60 (Pf Cpn) Protein | EMD004 |
| KmUD SUMO Protease | EWM102 |
| LF E687A (Anthrax Lethal Factor Mutant (LF E687A)) | ENH016-LT |
| LFn-Linker-Cys (Anthrax Lethal Factor Mutant (LFn-Linker-Cys)) | ENH015-LT |
| Mannan-Binding Lectin Serine Protease 1 (MASP-1) | ETL003 |
| Mannan-Binding Lectin Serine Protease 2 (MASP-2) | ETL004 |
| MetalloBuffer BufferTM Kit pZn 11-7 | KPG003 |
| MetalloBuffer BufferTM Kit pZn 13-9 | KPG002 |
| Morphinan N-demethylase (MND) | EDD004 |
| MTB DapE protein, RMTB003 100ug | FGN049 |
| MTB DapE protein, RMTB003 500ug | FGN050 |
| MTB DapE protein, RMTB003 1mg | FGN051 |
| MTB PDZ protein, RMTB004 100ug | FGN052 |
| MTB PDZ protein, RMTB004 500ug | FGN053 |
| MTB PDZ protein, RMTB004 1mg | FGN054 |
| MTB PepA Protein, RMTB001 100ug | FGN043 |
| MTB PepA Protein, RMTB001 500ug | FGN044 |
| MTB PepA Protein, RMTB001 1mg | FGN045 |
| MTB PepQ protein, RMTB002 100ug | FGN046 |
| MTB PepQ protein, RMTB002 500ug | FGN047 |
| MTB PepQ protein, RMTB002 1mg | FGN048 |
| Murine Myelin Basic Protein C1 Isoform (MBP - rmMBP-C1) | EGP004 |
| Murine Myelin Basic Protein C1 Isoform (MBP - S17C,T92,95E-UTC1) | EGP006 |
| Murine Myelin Basic Protein C1 Isoform (MBP - S17C,T95E-UTC1) | EGP007 |
| Murine Myelin Basic Protein C1 Isoform (MBP - UTC1) | EGP009 |
| Murine Myelin Basic Protein C1 Isoform, 1-105 (MBP - DC-rmMBP) | EGP003 |
| Murine Myelin Basic Protein C8 Charge Isoform (MBP - rmMBP-C8) | EGP005 |
| Murine Myelin Basic Protein C8 Charge Isoform (MBP - UTC8) | EGP010 |
| Murine Myelin Basic Protein, S133-S159, Calmodulin Binding Domain (MBP a3- peptide) | EGP012 |
| PA D512K (Anthrax Protective Mutant Antigen (PA-D512K)) | ENH011-LT |
| PA F427A (Anthrax Protective Mutant Antigen (PA F427A)) | ENH007-LT |
| PA K563C (Anthrax Protective Mutant Antigen (PA-K563C)) | ENH008-LT |
| PA L687A (Anthrax Protective Mutant Antigen (PA-L687A)) | ENH009-LT |
| PA-3M (Anthrax Protective Mutant Antigen (PA-3M)) | ENH004-LT |
| PA-3M Cys (Anthrax Protective Mutant Antigen (PA-3M Cys)) | ENH005-LT |
| PA-3M-SoSi-H6 (Anthrax Protective Mutant Antigen (PA-3M-SoSi-H6)) | ENH012-LT |
| PA-U7 (Anthrax Protective Mutant Antigen (PA-U7)) | ENH006-LT |
| PA-U7-K562C (Anthrax Protective Mutant Antigen (PA-U7-K562C)) | ENH010-LT |
| Pre-Formed Fibrils, A53T α-Synuclein (α-syn-A53T PFFs) | EGP014 |
| Pre-Formed Fibrils, E46K α-Synuclein (α-syn-E46K PFFs) | EGP016 |
| Recombinant HuD/ELAVL4 E Neoantigen | FCG005 |
| Recombinant HuD/ELAVL4 Neoantigen | FCG004 |
| Recombinant human CADM1 Fc-Fusion Protein | Kf-Pr00236-10.9 |
| Recombinant human CD226 Fc-Fusion Protein | Kf-Pr00123-10.9 |
| Recombinant human CD69 Fc-Fusion Protein | Kf-Pr00186-10.28 |
| Recombinant human CTLA-4 Fc-Fusion Protein | Kf-Pr00103-10.13 |
| Recombinant human EGFR Fc-Fusion Protein | Kf-Pr00117-10.9 |
| Recombinant Human Inactive Alpha Thrombin (S195A) | ESL002 |
| Recombinant Human Insulin 250mg | FCP001 |
| Recombinant Human Insulin 500mg | FCP002 |
| Recombinant Human Insulin 1g | FCP003 |
| Recombinant human NCAM1 Fc-Fusion Protein | Kf-Pr00241-10.9 |
| Recombinant human NCTR1 Fc-Fusion Protein | Kf-Pr00127-10.9 |
| Recombinant human NCTR3 Fc-Fusion Protein | Kf-Pr00126-10.9 |
| Recombinant human NKG2D Fc-Fusion Protein | Kf-Pr00125-10.28 |
| Recombinant human NKG2E Fc-Fusion Protein | Kf-Pr00128-10.28 |
| Recombinant human SLAF7 Fc-Fusion Protein | Kf-Pr00180-10.9 |
| Recombinant human TIGIT Fc-Fusion Protein | Kf-Pr00122-10.9 |
| Recombinant Human Wild-type Alpha Thrombin | ESL001 |
| Recombinant mouse 4-1BB Fc-Fusion Protein | Kf-Pr00233-1.9 |
| Recombinant mouse 4-1BBL Fc-Fusion Protein | Kf-Pr00159-1.28 |
| Recombinant mouse B7-H3 Fc-Fusion Protein | Kf-Pr00158-1.9 |
| Recombinant mouse BTLA Fc-Fusion Protein | Kf-Pr00224-1.9 |
| Recombinant mouse CD27 Fc-Fusion Protein | Kf-Pr00160-1.9 |
| Recombinant mouse CD47 (C33 to G mutation) Fc-Fusion Protein | Kf-Pr00113-1.9 |
| Recombinant mouse CD70 Fc-Fusion Protein | Kf-Pr00161-1.28 |
| Recombinant mouse CD80 Fc-Fusion Protein | Kf-Pr00225-1.9 |
| Recombinant mouse CD86 Fc-Fusion Protein | Kf-Pr00226-1.9 |
| Recombinant mouse CD96 Fc-Fusion Protein | Kf-Pr00230-1.9 |
| Recombinant mouse CTLA4 Fc-Fusion Protein | Kf-Pr00155-1.9 |
| Recombinant mouse ICOS Fc-Fusion Protein | Kf-Pr00153-1.9 |
| Recombinant mouse ICOSL Fc-Fusion Protein | Kf-Pr00157-1.9 |
| Recombinant mouse IL2 Fc-Fusion Protein | Kf-Pr00109-1.9 |
| Recombinant mouse Lag3 Fc-Fusion Protein | Kf-Pr00162-1.9 |
| Recombinant mouse OX40 Fc-Fusion Protein | Kf-Pr00154-1.9 |
| Recombinant mouse PD-1 Fc-Fusion Protein | Kf-Pr00152-1.9 |
| Recombinant mouse PDL1 Fc-Fusion Protein | Kf-Pr00112-1.9 |
| Recombinant mouse PDL2 Fc-Fusion Protein | Kf-Pr00156-1.9 |
| Recombinant mouse TIGIT Fc-Fusion Protein | Kf-Pr00163-1.9 |
| Recombinant mouse TIM-1 Fc-Fusion Protein | Kf-Pr00227-1.9 |
| Recombinant mouse TIM-3 Fc-Fusion Protein | Kf-Pr00228-1.9 |
| Recombinant mouse TNFR1 Fc-Fusion Protein | Kf-Pr00111-1.9 |
| Recombinant mouse VISTA Fc-Fusion Protein | Kf-Pr00164-1.9 |
| Recombinant p65-GST Protein 10ug | EH0005 |
| Recombinant p65-GST Protein 50ug | EH0006 |
| Recombinant TEV Protease | EGA311 |
| Salutaridine Synthase (CYP719B1) | EDD005 |
| SARS COV-2 RBD, GNGRBD_SSH 100ug | FGN061 |
| SARS COV-2 RBD, GNGRBD_SSH 500ug | FGN062 |
| SARS COV-2 RBD, GNGRBD_SSH 1mg | FGN063 |
| SARS COV-2 Spike S1, GNGS1-V16R 100ug | FGN058 |
| SARS COV-2 Spike S1, GNGS1-V16R 500ug | FGN059 |
| SARS COV-2 Spike S1, GNGS1-V16R 1mg | FGN060 |
| SARS-CoV-2 Envelope (E) Protein | ECR006 |
| SARS-CoV-2 Membrane (M) Protein | ECR007 |
| SARS-CoV-2 Nucleocapsid (N) Protein | ECR008 |
| SpyTag/SpyCatcher Protein Coupling Reagents | EOX003 |
| SpyTag/SpyCatcher Protein Coupling Reagents | EOX004 |
| SpyTag/SpyCatcher Protein Coupling Reagents | EOX005 |
| Streptavidin Mutein Matrix SAVSBPM18 | EUC012 |
| SUMO Protease (Ulp1p, M1_K402del) 100ug | EB1008-FP |
| SUMO Protease (Ulp1p, M1_K402del) 1mg | EB1009-FP |
| Swine GCSF, rPorcine GCSF 100ug | FGN034 |
| Swine GCSF, rPorcine GCSF 500ug | FGN035 |
| Swine GCSF, rPorcine GCSF 1mg | FGN036 |
| Tephrosin | ECM001 |
| Thaleiria Annulata cysteine Protease, rTACP01 100ug | FGN031 |
| Thaleiria Annulata cysteine Protease, rTACP01 500ug | FGN032 |
| Thaleiria Annulata cysteine Protease, rTACP01 1mg | FGN033 |
| Traptavidin Protein | EOX001 |
| Wild-Type PA (Anthrax Protective Antigen (PA)) | ENH003-LT |
| WT-apoCA-tagRFP Biosensor Protein | KPG006 |
| Description | Catalog No. |
| 22-Hydroxy-26-aminocholesterol 22-oxidase (CYP90G1) | EDD014 |
| 22-Hydroxycholesterol 26-hydroxylase/oxidase (CYP94N1) | EDD012 |
| 22-Hydroxycholesterol-26-al transaminase (GABAT1) | EDD013 |
| Branched Chain Amino-acid Transaminase-2 (BCAT2); Full-length Human | FCA010 |
| Cheilanthifoline Synthase (CYP719A14) | EDD007 |
| Cholesterol 22-hydroxylase (CYP90B27) | EDD011 |
| Cytochrome P450 Reductase (CPR) | EDD010 |
| Cytoplasmic [NiFe]-Hydrogenase (SHI) | EGA301 |
| Endoglycosidase F1 (Endo F1) | ED5002 |
| Engineered Diguanylate Cyclase | ESB009 |
| FK506 Binding Protein-12 (FKBP12, FKBP1A), human recombinant | FCA007 |
| Fluorescent U-tag SUMO Trapping Protein (KmUTAG-fl) | EWM103 |
| Free Methionine-(R)-Sulfoxide Reductase (fRMsr), (C84S, C94S) 50ug | EE2001 |
| Free Methionine-(R)-Sulfoxide Reductase (fRMsr), (C84S, C94S) 250ug | EE2002 |
| Guinea pig L-Asparaginase 100ug | EB0020-FP |
| Guinea pig L-Asparaginase 1mg | EB0021-FP |
| Histidyl-tRNA synthetase (HARS) 50ug | EVM101 |
| Histidyl-tRNA synthetase (HARS) 100ug | EVM108 |
| Histidyl-tRNA synthetase (HARS) 250ug | EVM109 |
| Histidyl-tRNA synthetase (HARS) 6x-His 50ug | EVM102 |
| Histidyl-tRNA synthetase (HARS) 6x-His 100ug | EVM110 |
| Histidyl-tRNA synthetase (HARS) 6x-His 250ug | EVM111 |
| Histidyl-tRNA synthetase (HARS) 6x-His, N-Catalytic Domain 50ug | EVM103 |
| Histidyl-tRNA synthetase (HARS) 6x-His, N-Catalytic Domain 100ug | EVM112 |
| Histidyl-tRNA synthetase (HARS) 6x-His, N-Catalytic Domain 250ug | EVM113 |
| Human Deoxycytidine Kinase (dCK) (R104M, D133A) 100ug | EB1005-FP |
| Human Deoxycytidine Kinase (dCK) (R104M, D133A) 1mg | EB1006-FP |
| Human Deoxycytidine Kinase (dCK) WT 100ug | EB1007-FP |
| Human Deoxycytidine Kinase (dCK) WT 1mg | EB1004-FP |
| Human Dipeptidase (PEPD) Inactive (G278D) Protein | EVC013 |
| Human Dipeptidase (PEPD) Protein | EVC012 |
| Isocitrate Dehydrogenase 1 (IDH1), (R132C) 20ug (1.9mg/mL) | FS1001 |
| Isocitrate Dehydrogenase 1 (IDH1), (R132C) 100ug (1.9mg/mL) | FS1002 |
| Isocitrate Dehydrogenase 1 (IDH1), (R132H) 20ug (5.76mg/mL) | FS1003 |
| Isocitrate Dehydrogenase 1 (IDH1), (R132H) 100ug (5.76mg/mL) | FS1004 |
| KmUD SUMO Protease | EWM102 |
| Liver glucokinase (GK); Full-length Human | FCA004 |
| MarathonRT Reverse Transcriptase 20uL (20 units/uL) | EYU007 |
| MarathonRT Reverse Transcriptase 20uL (20 units/uL) I | EYU008-FP |
| Morphinan N-demethylase (MND) | EDD004 |
| Non-Natural Promoter T7 Polymerase | EUT001 |
| Nonspecific DNA/RNA Nuclease | EVC010 |
| Norbelladine 4′-O-Methyltransferase (NpN4OMT) | EDD008 |
| Noroxomaritidine reductase (NNR) | EDD009 |
| Pancreatic glucokinase (GK); Full-length Human | FCA003 |
| Recombinant Human Inactive Alpha Thrombin (S195A) | ESL002 |
| Recombinant Human Wild-type Alpha Thrombin | ESL001 |
| Recombinant Microbial Catalase enz_cat_001, 0.5mL (65000 U/mL) | FSA001 |
| Recombinant Microbial Catalase enz_cat_001, 1mL (65000 U/mL) | FSA002 |
| Recombinant Microbial Catalase enz_cat_001, 2mL (65000 U/mL) | FSA003 |
| Recombinant Microbial Catalase enz_cat_001, 5mL (65000 U/mL) | FSA004 |
| Recombinant Microbial Catalase (Lyophilized Powder) 20mg | FSA014 |
| Recombinant Microbial Catalase (Lyophilized Powder) 100mg | FSA015 |
| Recombinant Microbial Glutamate Dehydrogenase (GDH) 100mg | FSA011 |
| Recombinant Microbial Glutamate Dehydrogenase (GDH) 500mg | FSA012 |
| Recombinant Microbial Glutamate Dehydrogenase (GDH) 1g | FSA013 |
| Recombinant Microbial Laccase 100mg | FSA016 |
| Recombinant Microbial Laccase 500mg | FSA017 |
| Recombinant TEV Protease | EGA311 |
| Stylopine Synthase (CYP719A13) | EDD006 |
| SUMO Protease (Ulp1p, M1_K402del) 100ug | EB1008-FP |
| SUMO Protease (Ulp1p, M1_K402del) 1mg | EB1009-FP |
| TEV HALO Magnetic Nanoparticles | ECU017 |
| Description | Catalog No. |
| Human Fibronectin III 1 N-GST | EUR105 |
| Human Fibronectin III 1,2 N-GST | EUR103 |
| Human Fibronectin III 1,2KADA N-GST | EUR104 |
| Human Fibronectin III 10 N-GST | EUR119 |
| Human Fibronectin III 11C C-His | EUR102 |
| Human Fibronectin III 12,13 N-GST | EUR120 |
| Human Fibronectin III 1-4 N-GST | EUR106 |
| Human Fibronectin III 1H N-GST | EUR110 |
| Human Fibronectin III 1H,8,10 N-GST | EUR107 |
| Human Fibronectin III 1H,8-10 N-GST | EUR108 |
| Human Fibronectin III 1H,8RGD N-GST | EUR109 |
| Human Fibronectin III 2 N-GST | EUR111 |
| Human Fibronectin III 4 | EUR113 |
| Human Fibronectin III 8-10 N-GST | EUR116 |
| Description | Catalog No. |
| Human Vitronectin N-GST (cell-binding domain) | EUR123 |
| Human Vitronectin N-GST (full-length) | EUR121 |
| Human Vitronectin N-GST (heparin-binding domain deletion) | EUR122 |
| Human Vitronectin N-GST (heparin-binding domain) | EUR125 |
| Human Vitronectin-SMB N-GST (PAI-1-binding; uPAR-binding; integrin-binding) | EUR124 |
| Description | Catalog No. |
| Rac1 Antagonist (W56) 1mg | EAA045 |
| Rac1 Antagonist (W56) 5mg | EAA046 |
| Description | Catalog No. |
| Maleoyl-beta-Ala-TAT 0.5mg | EAA004 |
| Maleoyl-beta-Ala-TAT 1mg | EAA005 |
| Description | Catalog No. |
| Maleoyl-beta-Ala-TAT 0.5mg | EAA004 |
| Maleoyl-beta-Ala-TAT 1mg | EAA005 |
| Description | Catalog No. |
| Anti-TNFSF13/APRIL [A3D8] Antibody | EMI027 |
| Anti-CCL4 [5E9] Antibody | EUS059 |
| Anti-CCL4 [4A5] Antibody | EUS060 |
| Anti-CCL4 [15D9] Antibody | EUS061 |
| Anti-CCL4 [1A1] Antibody | EUS062 |
| Anti-CCL4 [8E6] Antibody | EUS063 |
| Anti-CCL5 [12H11] Antibody | EUS069 |
| Anti-CCL5 [6H1] Antibody | EUS070 |
| Anti-CCL5 [6E11] Antibody | EUS071 |
| Anti-CCL5 [15E3] Antibody | EUS072 |
| Anti-CCL5 [8H11] Antibody | EUS073 |
| Anti-CCL5 [13D1] Antibody | EUS075 |
| Anti-CCL5 [11G1] Antibody | EUS076 |
| Anti-CCL5 [13G3] Antibody | EUS077 |
| Anti-IFN-alpha [15C1] Antibody | EUS078 |
| Anti-IFN-alpha [11H9] Antibody | EUS079 |
| Anti-IFN-alpha [6C8] Antibody | EUS080 |
| Anti-IFN-alpha [15G8] Antibody | EUS081 |
| Anti-IFN-alpha [9B4] Antibody | EUS082 |
| Anti-IL-2 [8] Antibody | EUS024 |
| Anti-IL-2 [4] Antibody | EUS023 |
| Anti-IL-2 [16] Antibody | EUS025 |
| Anti-IL-2 [3B8] Antibody | EUS064 |
| Anti-IL-2 [4E9] Antibody | EUS065 |
| Anti-IL-2 [11C3] Antibody | EUS066 |
| Anti-IL-2 [8H8] Antibody | EUS067 |
| Anti-IL-2 [14H9] Antibody | EUS068 |
| Anti-Interferon kappa [11F11] Antibody | EUS087 |
| Anti-Interferon kappa [11F6] Antibody | EUS088 |
| Anti-Interferon kappa [5A3] Antibody | EUS090 |
| Anti-Interferon kappa [11E9] Antibody | EUS091 |
| Anti-Interferon kappa [3G3] Antibody | EUS089 |
| Anti-IL-7 [4F12] Antibody | EUS083 |
| Anti-IL-7 [1B7] Antibody | EUS084 |
| Anti-IL-7 [1H6] Antibody | EUS085 |
| Anti-IL-7 [3D3] Antibody | EUS086 |
| Recombinant Human Insulin, 250mg | FCP001 |
| Recombinant Human Insulin, 500mg | FCP002 |
| Recombinant Human Insulin, 1g | FCP003 |
Green fluorescent protein (GFP), a 27 kDa protein derived from the jellyfish Aequorea victoria, emits green light (emission peak at a wavelength of 509 nm) when excited by blue light (excitation peak at a wavelength of 395 nm). Green Fluorescent Protein (GFP) has become an invaluable tool in cell biology research, since its intrinsic fluorescence can be visualized in living cells. GFP fluorescence is stable under fixation conditions and suitable for a variety of applications. GFP has been widely used as a reporter for gene expression, enabling researchers to visualize and localize GFP-tagged proteins within living cells without the need for chemical staining. Other applications of GFP include assessment of protein-protein interactions through the yeast two hybrid system and measurement of distance between proteins through fluorescence energy transfer (FRET) protocols. GFP is used to measure single cell metastasis and successful proliferation of stem cells. In these ways, GFP technology has contributed to a greater understanding of cellular biology and biochemistry.
| Description | Catalog No. |
| Ad CMV Cre - RSV eGFP | FVQ005 |
| Ad CMV eGFP | FVQ002 |
| Ad CMV eGFP - RSV Luc | FVQ013 |
| Ad CMV eGFP - RSV ntLacZ | FVQ016 |
| Ad CMV mSERCA2 - RSV eGFP | FVQ018 |
| Ad CMV p53 - RSV eGFP | FVQ028 |
| Ad CMV VEGF-C - RSV eGFP | FVQ028 |
| Ad RSV eGFP | FVQ023 |
| Ad RSV hPLAP - RSV eGFP | FVQ024 |
| Anti-GFP [8H12] Antibody | EST201 |
| CD44CR1-GFP Reporter Plasmid | ED4002 |
| LV-CMV-Cre-GFP, 2x25uL (1×10^8 TU/mL) | FCT072 |
| LV-CMV-Cre-GFP, 8x25uL (1×10^8 TU/mL) | FCT073 |
| Cre-GFP (PGK) Lentivirus (8x25uL) | FCT178 |
| Cre-GFP (PGK) Lentivirus (2x25uL) | FCT174 |
| EGFP (CAG) Lentivirus (2x25uL) | FCT148 |
| EGFP (CAG) Lentivirus (8x25uL) | FCT149 |
| Foxn4CR4.2-GFP Reporter Plasmid | ED4001 |
| LV-CMV-GFP (2×25 µl ) | FCT003 |
| LV-CMV-GFP ( 8×25 µl ) | FCT004 |
| LV-EF1A-GFP (2×25 µl ) | FCT066 |
| LV-EF1A-GFP ( 8×25 µl ) | FCT067 |
| GFP (Heat Inducible HSP70) Lentivirus (2x25uL) | FCT170 |
| GFP (Heat Inducible HSP70) Lentivirus (8x25uL) | FCT171 |
| GFP (Inducible Tet-On) Lentivirus (8x25uL) | FCT103 |
| GFP (Inducible Tet-On) Lentivirus (2x25uL) | FCT102 |
| GFP (PGK) Lentivirus | FCT175 |
| LV-UbC-GFP (2×25 µl ) | FCT040 |
| LV-UbC-GFP (8×25µl) | FCT041 |
| Notch1CR2-GFP Reporter Plasmid | ED4003 |
| Oct4-GFP Reporter Lentivirus (2x25uL) | FCT134 |
| Oct4-GFP Reporter Lentivirus (8x25uL) | FCT135 |
| Perkinsus marinus (CB5D4) PmMOE-GFP | EMD101 |
| Pseudotyped ΔG-GFP (G*ΔG-GFP) rVSV | EH1019-PM |
| Pseudotyped ΔG-GFP (G*ΔG-GFP) rVSVw/ pCAGGS-G-Kan | EH1024-PM |
| Pseudotyped ΔG-SEAP (G*ΔG-SEAP) rVSV | EH1035-PM |
| Pseudotyped ΔG-SEAP (G*ΔG-SEAP) rVSV w/ pCAGGS-G-Kan | EH1036-PM |
| pVSV-ΔG-GFP Plasmid Expression Vector | EH1003 |
| VSV-ΔG-GFP Plasmid Expression Vector System | EH1004 |
| VSV-ΔG-GFP-2.6 Plasmid Expression Vector | EH1026 |
| VSV-ΔG-GFP-2.6 Plasmid Expression Vector System | EH1027 |
| pVSV-ΔL-GFP Plasmid Expression Vector | EH1009 |
| VSV-ΔL-GFP Plasmid Expression Vector System | EH1010 |
In order to enter protein synthesis, all amino acids must first be joined to transfer RNAs (tRNAs), which serve as the adaptors of the genetic code. This reaction is catalyzed by the aminoacyl-tRNA synthetases (aaRSs).
| Description | Catalog No. |
| Histidyl-tRNA synthetase (HARS), 50ug | EVM101 |
| Histidyl-tRNA synthetase (HARS), 100ug | EVM108 |
| Histidyl-tRNA synthetase (HARS), 250ug | EVM109 |
| Histidyl-tRNA synthetase (HARS) 6x-His, 50ug | EVM102 |
| Histidyl-tRNA synthetase (HARS) 6x-His, 100ug | EVM110 |
| Histidyl-tRNA synthetase (HARS) 6x-His, 250ug | EVM111 |
| Histidyl-tRNA synthetase (HARS) 6x-His, N-Catalytic Domain, 50ug | EVM103 |
| Histidyl-tRNA synthetase (HARS) 6x-His, N-Catalytic Domain, 100ug | EVM112 |
| Histidyl-tRNA synthetase (HARS) 6x-His, N-Catalytic Domain, 250ug | EVM113 |
| pHRS7-Histidyl-tRNA Synthetase (E.coli) | EVM104 |
| pJA15-Template for in vitro tRNA expression | EVM107 |
| pQE30-N-Catalytic Domain Histidyl-tRNA Synthetase (E. coli) w/6x His-tag | EVM106 |
| pWY30-Histidyl-tRNA Synthetase (E. coli) w/6x His-tag | EVM105 |
Fc-Fusion proteins (also known as Fc chimeric fusion proteins, Fc-Ig’s, Ig-based Chimeric Fusion proteins and Fc-tag proteins) are composed of the Fc domain of IgG genetically linked to a peptide or protein of interest. Fc-Fusion proteins have become valuable reagents for in vivo and in vitro research.
Examples of Fc-fused binding partners include, but are not limited to, single peptides, ligands activated upon cell-surface receptor binding, signaling molecules, extracellular domains of receptors activated upon dimerization and bait proteins used to identify binding partners in protein microarrays.
One of the most valuable characteristics conferred by the Fc domain in vivo is the dramatic prolonging of the plasma half-life (t1/2) of the protein of interest, which for biotherapeutic drugs can result in improved therapeutic efficacy; an attribute that has made Fc-Fusion proteins attractive biotherapeutic agents.
In vitro applications of Fc-Fusion proteins include, amongst others, immunohistochemistry (IHC), flow cytometry (FC), protein binding assays and use as microarray baits. In these applications, the Fc domain behaves as a supporting module to which proteins can be attached whilst retaining their native biological activity. The Fc domain can also improve the in vivo and in vitro solubility and stability of some binding partners.
We’re excited to offer a large selection of Fc-Fusion proteins from our sister company Absolute Antibody, which specializes in engineering unique recombinant antibodies and proteins.
| Description | Catalog No. |
| Recombinant human CADM1 Fc-Fusion Protein | Kf-Pr00236-10.9 |
| Recombinant human CD226 Fc-Fusion Protein | Kf-Pr00123-10.9 |
| Recombinant human CD69 Fc-Fusion Protein | Kf-Pr00186-10.28 |
| Recombinant human CTLA-4 Fc-Fusion Protein | Kf-Pr00103-10.13 |
| Recombinant human EGFR Fc-Fusion Protein | Kf-Pr00117-10.9 |
| Recombinant human NCAM1 Fc-Fusion Protein | Kf-Pr00241-10.9 |
| Recombinant human NCTR1 Fc-Fusion Protein | Kf-Pr00127-10.9 |
| Recombinant human NCTR3 Fc-Fusion Protein | Kf-Pr00126-10.9 |
| Recombinant human NKG2D Fc-Fusion Protein | Kf-Pr00125-10.28 |
| Recombinant human NKG2E Fc-Fusion Protein | Kf-Pr00128-10.28 |
| Recombinant human SLAF7 Fc-Fusion Protein | Kf-Pr00180-10.9 |
| Recombinant human TIGIT Fc-Fusion Protein | Kf-Pr00122-10.9 |
| Recombinant mouse 4-1BB Fc-Fusion Protein | Kf-Pr00233-1.9 |
| Recombinant mouse 4-1BBL Fc-Fusion Protein | Kf-Pr00159-1.28 |
| Recombinant mouse B7-H3 Fc-Fusion Protein | Kf-Pr00158-1.9 |
| Recombinant mouse BTLA Fc-Fusion Protein | Kf-Pr00224-1.9 |
| Recombinant mouse CD27 Fc-Fusion Protein | Kf-Pr00160-1.9 |
| Recombinant mouse CD47 (C33 to G mutation) Fc-Fusion Protein | Kf-Pr00113-1.9 |
| Recombinant mouse CD70 Fc-Fusion Protein | Kf-Pr00161-1.28 |
| Recombinant mouse CD80 Fc-Fusion Protein | Kf-Pr00225-1.9 |
| Recombinant mouse CD86 Fc-Fusion Protein | Kf-Pr00226-1.9 |
| Recombinant mouse CD96 Fc-Fusion Protein | Kf-Pr00230-1.9 |
| Recombinant mouse CTLA4 Fc-Fusion Protein | Kf-Pr00155-1.9 |
| Recombinant mouse ICOS Fc-Fusion Protein | Kf-Pr00153-1.9 |
| Recombinant mouse ICOSL Fc-Fusion Protein | Kf-Pr00157-1.9 |
| Recombinant mouse IL2 Fc-Fusion Protein | Kf-Pr00109-1.9 |
| Recombinant mouse Lag3 Fc-Fusion Protein | Kf-Pr00162-1.9 |
| Recombinant mouse OX40 Fc-Fusion Protein | Kf-Pr00154-1.9 |
| Recombinant mouse PD-1 Fc-Fusion Protein | Kf-Pr00152-1.9 |
| Recombinant mouse PDL1 Fc-Fusion Protein | Kf-Pr00112-1.9 |
| Recombinant mouse PDL2 Fc-Fusion Protein | Kf-Pr00156-1.9 |
| Recombinant mouse TIGIT Fc-Fusion Protein | Kf-Pr00163-1.9 |
| Recombinant mouse TIM-1 Fc-Fusion Protein | Kf-Pr00227-1.9 |
| Recombinant mouse TIM-3 Fc-Fusion Protein | Kf-Pr00228-1.9 |
| Recombinant mouse TNFR1 Fc-Fusion Protein | Kf-Pr00111-1.9 |
| Recombinant mouse VISTA Fc-Fusion Protein | Kf-Pr00164-1.9 |
| Description | Catalog No. |
| Histone H4 (N-term 6xHis-tag, human recombinant) | FS0004 |
| Anti-Polycomb group protein Psc [1F4-E1-E2] Antibody | EG1024 |
| Anti-Polycomb group protein Psc [6E8-E6-A8] Antibody | EG1025 |
| Description | Catalog No. |
| EBV-Conditioned SML Medium | ESA118 |
| Epstein Barr Virus (EBV) | FB0002 |
Adenoviruses are able to introduce foreign genes into target, host cells efficiently, making the virus attractive as a research tool in cell biology. Adenoviruses have a very broad host range, and can infect human and other mammalian cell lines or primary cells, including replicative as well as non-replicative cells. There are in fact very few cell lines that cannot be infected.
| Description | Catalog No. |
| Ad CMV CD 54 | FVQ006 |
| Ad CMV Cre | FVQ004 |
| Ad CMV Cre - RSV eGFP | FVQ005 |
| Ad CMV CXCL-10 | FVQ007 |
| Ad CMV eGFP | FVQ002 |
| Ad CMV eGFP - RSV Luc | FVQ013 |
| Ad CMV eGFP - RSV ntLacZ | FVQ016 |
| Ad CMV GM-CSF2 | FVQ012 |
| Ad CMV IL-12 | FVQ008 |
| Ad CMV IL-18 | FVQ009 |
| Ad CMV mSERCA2 | FVQ017 |
| Ad CMV mSERCA2 - RSV eGFP | FVQ018 |
| Ad CMV mTGFb | FVQ014 |
| Ad CMV Nrf2 (porcine) | FVQ025 |
| Ad CMV ntLacZ | FVQ003 |
| Ad CMV p53 | FVQ011 |
| Ad CMV p53 - RSV eGFP | FVQ019 |
| Ad CMV PPARg2 | FVQ020 |
| Ad CMV SOD3 | FVQ015 |
| Ad CMV VEGF-C - RSV eGFP | FVQ028 |
| Ad EMPTY | FVQ001 |
| Ad RSV cytoLacZ | FVQ021 |
| Ad RSV eGFP | FVQ023 |
| Ad RSV hPLAP - RSV eGFP | FVQ024 |
| Ad RSV Luc | FVQ026 |
| Ad RSV ntLacZ | FVQ022 |
Vesicular stomatitis virus (VSV) is a widely used model system for studying both virus replication and virus assembly. It consists of a bullet-shaped virion composed of five viral proteins, a single molecule of negative-sense RNA, and a lipid envelope derived from the host cell plasma membrane.
| Description | Catalog No. |
| Anti-VSV-G [8G5F11] Antibody | EB0010 |
| Recombinant Anti-VSV-G [8G5F11], Human, IgG1k | Kf-Ab01401-10.0 |
| Recombinant Anti-VSV-G [8G5F11], Mouse, IgG2ak | Kf-Ab01401-2.0 |
| Recombinant Anti-VSV-G [8G5F11], Mouse, IgG2ak | Kf-Ab01401-2.3 |
| Recombinant Anti-VSV-G [8G5F11], Rabbit, IgGk | Kf-Ab01401-23.0 |
| Anti-VSV-G [IE9F9] Antibody | EB0012 |
| Recombinant Anti-VSV-G [IE9F9], Human, IgG1k | Kf-Ab01402-10.0 |
| Recombinant Anti-VSV-G [IE9F9], Human, IgG1k | Kf-Ab01402-10.3 |
| Recombinant Anti-VSV-G [IE9F9], Human, IgMk | Kf-Ab01402-15.0 |
| Recombinant Anti-VSV-G [IE9F9], Mouse, IgG2ak | Kf-Ab01402-2.0 |
| Recombinant Anti-VSV-G [IE9F9], Mouse, IgG2ak | Kf-Ab01402-2.3 |
| Recombinant Anti-VSV-G [IE9F9], Mouse, IgMk | Kf-Ab01402-21.0 |
| Recombinant Anti-VSV-G [IE9F9], Rabbit, IgGk | Kf-Ab01402-23.0 |
| Anti-VSV-M [23H12] Antibody | EB0011 |
| Recombinant Anti-VSV-M [23H12], Human, IgG1k | Kf-Ab01404-10.0 |
| Recombinant Anti-VSV-M [23H12], Human, IgG1k | Kf-Ab01404-10.3 |
| Recombinant Anti-VSV-M [23H12], Human, IgMk | Kf-Ab01404-15.0 |
| Recombinant Anti-VSV-M [23H12], Mouse, IgG2ak | Kf-Ab01404-2.0 |
| Recombinant Anti-VSV-M [23H12], Mouse, IgG2ak | Kf-Ab01404-2.3 |
| Recombinant Anti-VSV-M [23H12], Mouse, IgMk | Kf-Ab01404-21.0 |
| Recombinant Anti-VSV-M [23H12], Rabbit, IgGk | Kf-Ab01404-23.0 |
| BHK-21/WI-2 cells for Generating VSV | EH1011 |
| pBS-G-ФT Plasmid | EH1016 |
| pBS-L-ФT Plasmid | EH1015 |
| pBS-N-ФT Plasmid | EH1013 |
| pBS-P-ФT Plasmid | EH1014 |
| pCAGGS-G-Kan Plasmid | EH1017 |
| pET 21d.1 VSV-M (M51R) plasmid | EB0002 |
| pET 21d.1 VSV-M plasmid | EB0001 |
| pSD VSV-M (M51R) plasmid | EB0004 |
| pSD VSV-M plasmid | EB0003 |
| Pseudotyped Δ-G/CHIKV-E-NLucP rVSV | EGA316-PM |
| Pseudotyped Δ-G/EBOV-GP-NLucP rVSV | EGA297-PM |
| Pseudotyped Δ-G/LASV-GP-NLucP rVSV | EGA299-PM |
| Pseudotyped Δ-G/SARS-CoV-2-S_D614Gd21-NLucP rVSV | EGA298-PM |
| Pseudotyped Δ-G/VSV-G-NLucP rVSV | EGA317-PM |
| Pseudotyped ΔG-DsRed (G*ΔG-DsRed) rVSV | EH1018-PM |
| Pseudotyped ΔG-DsRed (G*ΔG-DsRed) rVSV w/ pCAGGS-G-Kan | EH1023-PM |
| Pseudotyped ΔG-GFP (G*ΔG-GFP) rVSV | EH1019-PM |
| Pseudotyped ΔG-GFP (G*ΔG-GFP) rVSVw/ pCAGGS-G-Kan | EH1024-PM |
| Pseudotyped ΔG-luciferase (G*ΔG-luciferase) rVSV | EH1020-PM |
| Pseudotyped ΔG-luciferase (G*ΔG-luciferase) rVSVw/ pCAGGS-G-Kan | EH1025-PM |
| Pseudotyped ΔG-SEAP (G*ΔG-SEAP) rVSV | EH1035-PM |
| Pseudotyped ΔG-SEAP (G*ΔG-SEAP) rVSV w/ pCAGGS-G-Kan | EH1036-PM |
| pVSV-Δ-G-CHIKV-E_nLucP Plasmid | EGA294 |
| pVSV-Δ-G-EBOV-GP_nLucP Plasmid | EGA291 |
| pVSV-Δ-G-SARS-CoV-2-S_nLucP Plasmid | EGA292 |
| pVSV-Δ-G-VSV-G_nLucP Plasmid | EGA295 |
| Set of Helper Plasmids (VSV-N, VSV-P, VSV-L, VSV-G) | EH1012 |
| VSV-FL+(2) VSV Plasmid Expression Vector | EH1001 |
| VSV-FL+(2) VSV Plasmid Expression Vector System | EH1002 |
| pVSV-ΔG-DsRed Plasmid Expression Vector | EH1005 |
| VSV-ΔG-DsRed Plasmid Expression Vector System | EH1006 |
| VSV-ΔG-GFP Plasmid Expression Vector | EH1003 |
| VSV-ΔG-GFP Plasmid Expression Vector System | EH1004 |
| VSV-ΔG-GFP-2.6 Plasmid Expression Vector | EH1026 |
| VSV-ΔG-GFP-2.6 Plasmid Expression Vector System | EH1027 |
| pVSV-ΔG-Luciferase Plasmid Expression Vector | EH1007 |
| VSV-ΔG-Luciferase Plasmid Expression Vector System | EH1008 |
| VSV-ΔG-N/P-MCS2-2.6 Plasmid Expression Vector | EH1028 |
| VSV-ΔG-N/P-MCS2-2.6 Plasmid Expression Vector System | EH1029 |
| VSV-ΔG-P/M-MCS2-2.6 Plasmid Expression Vector | EH1032 |
| VSV-ΔG-P/M-MCS2-2.6 Plasmid Expression Vector System | EH1033 |
| VSV-ΔG-PL 2.5 Plasmid Expression Vector | EH1030 |
| VSV-ΔG-PL 2.5 Plasmid Expression Vector System | EH1031 |
| pVSV-ΔL-GFP Plasmid Expression Vector | EH1009 |
| VSV-ΔL-GFP Plasmid Expression Vector System | EH1010 |
Lentiviral vector transduction is a powerful tool for delivering target genes into almost all types of dividing and non-dividing mammalian cells in vitro and in vivo.
| Description | Catalog No. |
| Ars2 (Inducible Tet-On) Lentivirus (2x25uL) | FCT116 |
| Ars2 (Inducible Tet-On) Lentivirus (8x25uL) | FCT117 |
| ASCL1 (Inducible Tet-On) Lentivirus, 2x25ul | FCT208 |
| SCL1 (Inducible Tet-On) Lentivirus, 8x25ul | FCT209 |
| Brn2 (Inducible Tet-On) Lentivirus, 2x25ul | FCT206 |
| Brn2 (Inducible Tet-On) Lentivirus, 8x25ul | FCT207 |
| Calcium Indicator GCaMP3 (CMV) Lentivirus, 2x25ul | FCT188 |
| Calcium Indicator GCaMP3 (CMV) Lentivirus, 8x25ul | FCT189 |
| CHX10 (Inducible Tet-On) Lentivirus (2x25uL) | FCT114 |
| CHX10 (Inducible Tet-On) Lentivirus (8x25uL) | FCT115 |
| LV-CMV-C-MYC (2×25 µl ) | FCT009 |
| LV-CMV-C-MYC ( 8×25 µl ) | FCT010 |
| LV-EF1A-C-MYC (2×25 µl ) | FCT019 |
| LV-EF1A-C-MYC ( 8×25 µl ) | FCT020 |
| C-MYC (Inducible Tet-On) Lentivirus (2x25uL) | FCT100 |
| C-MYC (Inducible Tet-On) Lentivirus (8x25uL) | FCT101 |
| LV-CMV-Cre, 2x25uL (1×10^8 TU/mL) | FCT080 |
| LV-CMV-Cre, 8x25uL (1×10^8 TU/mL) | FCT081 |
| Cre (PGK) Firefly Luciferase (CMV) Lentivirus (2x25uL) | FCT152 |
| Cre (PGK) Firefly Luciferase (CMV) Lentivirus (8x25uL) | FCT153 |
| LV-PGK-Cre, 2x25uL (1×10^8 TU/mL) | FCT070 |
| LV-PGK-Cre, 8x25uL (1×10^8 TU/mL) | FCT071 |
| Cre (PGK) Renilla Luciferase (CMV) Lentivirus (2x25uL) | FCT150 |
| Cre (PGK) Renilla Luciferase (CMV) Lentivirus (8x25uL) | FCT151 |
| LV-CMV-Cre-GFP, 2x25uL (1×10^8 TU/mL) | FCT072 |
| V-CMV-Cre-GFP, 8x25uL (1×10^8 TU/mL) | FCT073 |
| Cre-GFP (PGK) Lentivirus (8x25uL) | FCT178 |
| Cre-GFP (PGK) Lentivirus (2x25uL) | FCT174 |
| Cre-RFP (UBC) Lentivirus, 2x25ul | FCT224 |
| Cre-RFP (UBC) Lentivirus, 8x25ul | FCT225 |
| CRX (Inducible Tet-On) Lentivirus (2x25uL) | FCT110 |
| CRX (Inducible Tet-On) Lentivirus (8x25uL) | FCT111 |
| Custom Lentivirus Production | FCTC02 |
| EGFP (CAG) Lentivirus (2x25uL) | FCT148 |
| EGFP (CAG) Lentivirus (8x25uL) | FCT149 |
| Firefly Luciferase (CMV, blasticidin) Lentivirus (2x25uL) | FCT230 |
| Firefly Luciferase (CMV, blasticidin) Lentivirus (8x25uL) | FCT231 |
| Firefly Luciferase (CMV, neomycin) Lentivirus (2x25uL) | FCT160 |
| Firefly Luciferase (CMV, neomycin) Lentivirus (8x25uL) | FCT161 |
| LV-CMV-Firefly luciferase ( 2×25 µl ) | FCT005 |
| LV-CMV-Firefly luciferase ( 8×25 µl ) | FCT006 |
| Firefly Luciferase (UbC) Lentivirus (2x25uL) | FCT158 |
| Firefly Luciferase (UbC) Lentivirus (8x25uL) | FCT159 |
| Firefly Luciferase-IRES (CMV, puromycin) Lentivirus, 2x25ul | FCT226 |
| Firefly Luciferase-IRES (CMV, puromycin) Lentivirus, 8x25ul | FCT227 |
| FoxD1 (Inducible Tet-On) Lentivirus (2x25uL) | FCT126 |
| FoxD1 (Inducible Tet-On) Lentivirus (8x25uL) | FCT127 |
| FOXG1 (Inducible Tet-On) Lentivirus (2x25uL) | FCT168 |
| FOXG1 (Inducible Tet-On) Lentivirus (8x25uL) | FCT169 |
| GCaMP3 (CMV) Lentivirus (2x25uL) | FCT172 |
| GCaMP3 (CMV) Lentivirus (8x25uL) | FCT173 |
| LV-CMV-GFP (2×25 µl ) | FCT003 |
| LV-CMV-GFP ( 8×25 µl ) | FCT004 |
| LV-EF1A-GFP (2×25 µl ) | FCT066 |
| LV-EF1A-GFP ( 8×25 µl ) | FCT067 |
| GFP (Heat Inducible HSP70) Lentivirus (2x25uL) | FCT170 |
| GFP (Heat Inducible HSP70) Lentivirus (8x25uL) | FCT171 |
| GFP (Inducible Tet-On) Lentivirus (8x25uL) | FCT103 |
| GFP (Inducible Tet-On) Lentivirus (2x25uL) | FCT102 |
| GFP (PGK) Lentivirus | FCT175 |
| LV-UbC-GFP (2×25 µl ) | FCT040 |
| LV-UbC-GFP (8×25µl) | FCT041 |
| GFP-IRES (CMV, puromycin) Lentivirus, 2x25ul | FCT222 |
| GFP-IRES (CMV, puromycin) Lentivirus, 8x25ul | FCT223 |
| HLF (EF1A) Lentivirus (2x25uL) | FCT154 |
| HLF (EF1A) Lentivirus (8x25uL) | FCT155 |
| Hnf4a (Inducible Tet-On) Lentivirus (2x25uL) | FCT120 |
| Hnf4a (Inducible Tet-On) Lentivirus (8x25uL) | FCT121 |
| LV-CMV-KLF4 (2×25 µl ) | FCT011 |
| LV-CMV-KLF4 ( 8×25 µl ) | FCT012 |
| LV-EF1A-KLF4 (2×25 µl ) | FCT021 |
| LV-EF1A-KLF4 ( 8×25 µl ) | FCT022 |
| KLF4 (Inducible Tet-On) Lentivirus (2x25uL) | FCT096 |
| KLF4 (Inducible Tet-On) Lentivirus (8x25uL) | FCT097 |
| LV-CMV-LacZ (2×25 µl ) | FCT001 |
| LV-CMV-LacZ ( 8×25 µl ) | FCT002 |
| LHX2 (CMV) Lentivirus, 2x25ul | FCT214 |
| LHX2 (CMV) Lentivirus, 8x25ul | FCT215 |
| LV-EF1A-LIN28 (2×25 µl ) | FCT029 |
| LV-EF1A-LIN28 ( 8×25 µl ) | FCT030 |
| LivePAR Lentivirus | ESA003 |
| LV-CMV-L-MYC (2×25 µl ) | FCT017 |
| LV-CMV-L-MYC ( 8×25 µl ) | FCT018 |
| MAD2 (CMV) Lentivirus, 2x25ul | FCT196 |
| MAD2 (CMV) Lentivirus, 8x25ul | FCT197 |
| miR-182 (Inducible Tet-On) Lentivirus (2x25uL) | FCT136 |
| miR-182 (Inducible Tet-On) Lentivirus (8x25uL) | FCT137 |
| miR-183 (Inducible Tet-On) Lentivirus (2x25uL) | FCT138 |
| miR-183 (Inducible Tet-On) Lentivirus (8x25uL) | FCT139 |
| miR-200b,a, 429 (Inducible Tet-On) Lentivirus (2x25uL) | FCT122 |
| miR-200b,a, 429 (Inducible Tet-On) Lentivirus (8x25uL) | FCT123 |
| miR-204 (Inducible Tet-On) Lentivirus (2x25uL) | FCT094 |
| miR-204 (Inducible Tet-On) Lentivirus (8x25uL) | FCT095 |
| miR-211 (EF1A) Lentivirus (2x25uL) | FCT108 |
| miR-211 (EF1A) Lentivirus (8x25uL) | FCT109 |
| miR-211 (Inducible Tet-On) Lentivirus (2x25uL) | FCT124 |
| miR-211 (Inducible Tet-On) Lentivirus (8x25uL) | FCT125 |
| miR-302 (Inducible Tet-On) Lentivirus (2x25uL) | FCT092 |
| miR-302 (Inducible Tet-On) Lentivirus (8x25uL) | FCT093 |
| MITF-A (CMV) Lentivirus, 2x25ul | FCT204 |
| MITF-A (CMV) Lentivirus, 8x25ul | FCT205 |
| Mitf-D (Inducible Tet-On) Lentivirus (2x25uL) | FCT132 |
| Mitf-D (Inducible Tet-On) Lentivirus (8x25uL) | FCT133 |
| MITF-D (Inducible Tet-On, blasticidin) Lentivirus, 2x25ul | FCT220 |
| MITF-D (Inducible Tet-On, blasticidin) Lentivirus, 8x25ul | FCT221 |
| MITF-H (CMV) Lentivirus, 2x25ul | FCT218 |
| MITF-H (CMV) Lentivirus, 8x25ul | FCT219 |
| LV-EF1A-NANOG (2×25 µl ) | FCT027 |
| LV-EF1A-NANOG ( 8×25 µl ) | FCT028 |
| NANOG_h (EF1A) Lentivirus, 2x25ul | FCT186 |
| NANOG_h (EF1A) Lentivirus, 8x25ul | FCT187 |
| NEUROD1 (Inducible Tet-On) Lentivirus, 2x25ul | FCT210 |
| NEUROD1 (Inducible Tet-On) Lentivirus, 8x25ul | FCT211 |
| NFkB Firefly Luciferase Reporter Lentivirus (2x25uL) | FCT176 |
| NFkB Firefly Luciferase Reporter Lentivirus (8x25uL) | FCT177 |
| Firefly Luciferase (CMV, blasticidin) Lentivirus (2x25uL) | FCT230 |
| Firefly Luciferase (CMV, blasticidin) Lentivirus (8x25uL) | FCT231 |
| LV-CMV-N-MYC (8×25 µl ) | FCT036 |
| LV-CMV-N-MYC (2×25 µl ) | FCT035 |
| NR2E3 (Inducible Tet-On) Lentivirus (2x25uL) | FCT140 |
| NR2E3 (Inducible Tet-On) Lentivirus (8x25uL) | FCT141 |
| Nrl (Inducible Tet-On) Lentivirus (2x25uL) | FCT128 |
| Nrl (Inducible Tet-On) Lentivirus (8x25uL) | FCT129 |
| LV-CMV-OCT3/4 (2×25 µl ) | FCT013 |
| LV-CMV-OCT3/4 ( 8×25 µl ) | FCT014 |
| LV-EF1A-OCT3/4 (2×25 µl ) | FCT023 |
| LV-EF1A-OCT3/4 ( 8×25 µl ) | FCT024 |
| OCT3/4 (Inducible Tet-On) Lentivirus (2x25uL) | FCT090 |
| OCT3/4 (Inducible Tet-On) Lentivirus (8x25uL) | FCT091 |
| Oct4-GFP Reporter Lentivirus (2x25uL) | FCT134 |
| Oct4-GFP Reporter Lentivirus (8x25uL) | FCT135 |
| OSKM (CMV) Lentivirus (2x25uL) | FCT106 |
| OSKM (CMV) Lentivirus (8x25uL) | FCT107 |
| OSKM (Inducible Tet-On) Lentivirus, 2x25ul | FCT212 |
| OSKM (Inducible Tet-On) Lentivirus, 8x25ul | FCT213 |
| OTX2 (CMV) Lentivirus, 2x25ul | FCT194 |
| OTX2 (CMV) Lentivirus, 8x25ul | FCT195 |
| OTX2 (Inducible Tet-On) Lentivirus, 2x25ul | FCT190 |
| OTX2 (Inducible Tet-On) Lentivirus, 8x25ul | FCT191 |
| Pax6 (CMV) Lentivirus, 2x25ul | FCT216 |
| Pax6 (CMV) Lentivirus, 8x25ul | FCT217 |
| PAX6 (Inducible Tet-On) Lentivirus (2x25uL) | FCT112 |
| PAX6 (Inducible Tet-On) Lentivirus (8x25uL) | FCT113 |
| PKNOX2 (Inducible Tet-On) Lentivirus (2x25uL) | FCT118 |
| PKNOX2 (Inducible Tet-On) Lentivirus (8x25uL) | FCT119 |
| PRDM1 (Inducible Tet-On) Lentivirus (2x25uL) | FCT142 |
| PRDM1 (Inducible Tet-On) Lentivirus (8x25uL) | FCT143 |
| RAX (CMV) Lentivirus, 2x25ul | FCT200 |
| RAX (CMV) Lentivirus, 8x25ul | FCT201 |
| Redluc (CMV, puromycin) Lentivirus (2x25uL) | FCT232 |
| Redluc (CMV, puromycin) Lentivirus (8x25uL) | FCT233 |
| LV-CMV-Renilla luciferase ( 2×25 µl ) | FCT007 |
| LV-CMV-Renilla luciferase ( 8×25 µl ) | FCT008 |
| RFP (CAG) Lentivirus, 2x25ul | FCT180 |
| RFP (CAG) Lentivirus, 8x25ul | FCT181 |
| LV-CMV-RFP (2x25ul) | FCT068 |
| LV-CMV-RFP (8x25ul) | FCT069 |
| RFP (EF1A) Lentivirus, 2x25ul | FCT182 |
| RFP (EF1A) Lentivirus, 8x25ul | FCT183 |
| ROR-beta (Inducible Tet-On) Lentivirus (2x25uL) | FCT144 |
| ROR-beta (Inducible Tet-On) Lentivirus (8x25uL) | FCT145 |
| rtTA (CMV, neomycin) Lentivirus (2x25uL) | FCT146 |
| rtTA (CMV, neomycin) Lentivirus (8x25uL) | FCT147 |
| LV-CMV-rtTA (2×25 µl ) | FCT045 |
| LV-CMV-rtTA (8×25µl) | FCT047 |
| Set of factors (CMV-driven SOX2, OCT3/4, KLF4 and C-MYC) (4×25 µl ) | FCT031 |
| Set of factors (CMV-driven SOX2, OCT3/4, KLF4 and C-MYC) (4x4x25 µl ) | FCT032 |
| Set of factors (EF1A-driven LIN28, NANOG, SOX2, OCT3/4, KLF4 and C-MYC) (6×25 µl ) | FCT033 |
| Set of factors (EF1A-driven LIN28, NANOG, SOX2, OCT3/4, KLF4 and C-MYC) (6x4x25 µl ) | FCT034 |
| Set of Lentivirus (Tet-driven SOX2, OCT3/4, KLF4 and C-MYC) (4x25uL) | FCT104 |
| Set of Lentivirus (Tet-driven SOX2, OCT3/4, KLF4 and C-MYC) (4x4x25uL) | FCT105 |
| SIX3 (CMV) Lentivirus, 2x25ul | FCT198 |
| SIX3 (CMV) Lentivirus, 8x25ul | FCT199 |
| Six6 (CMV) Lentivirus, 8x25ul | FCT203 |
| Six6 (CMV) Lentivirus, 2x25ul | FCT202 |
| Smad6 (Inducible Tet-On) Lentivirus (2x25uL) | FCT130 |
| Smad6 (Inducible Tet-On) Lentivirus (8x25uL) | FCT131 |
| LV-CMV-SOX2 (2×25 µl ) | FCT015 |
| LV-CMV-SOX2 ( 8×25 µl ) | FCT016 |
| LV-EF1A-SOX2 (2×25 µl ) | FCT025 |
| LV-EF1A-SOX2 ( 8×25 µl ) | FCT026 |
| SOX2 (Inducible Tet-On) Lentivirus (2x25uL) | FCT098 |
| SOX2 (Inducible Tet-On) Lentivirus (8x25uL) | FCT099 |
| SOX9 (Inducible Tet-On) Lentivirus (2x25uL) | FCT166 |
| SOX9 (Inducible Tet-On) Lentivirus (8x25uL) | FCT167 |
| STAT3 Dominant Negative (Y705F) Lentivirus, 25uL | EH0007 |
| STAT3 Dominant Negative (Y705F) Lentivirus, 5x25uL | EH0008 |
| STAT3 Firefly Luciferase Reporter Lentivirus (puromycin) (2x25uL) | FCT162 |
| STAT3 Firefly Luciferase Reporter Lentivirus (puromycin) (8x25uL) | FCT163 |
| STAT3 Firefly Luciferase Reporter Lentivirus (neomycin) (2x25uL) | FCT164 |
| STAT3 Firefly Luciferase Reporter Lentivirus (neomycin) (8x25uL) | FCT165 |
| TGF/SMAD Reporter Lentivirus, 2x25ul | FCT228 |
| TGF/SMAD Reporter Lentivirus, 8x25ul | FCT229 |
| TNFSF12 (CMV) Lentivirus (2x25uL) | FCT156 |
| TNFSF12 (CMV) Lentivirus (8x25uL) | FCT157 |
| LV-CMV-vector control ( 2×25 µl ) | FCT038 |
| LV-CMV-vector control (8×25µl) | FCT039 |
| Vector Control (EF1A) Lentivirus, 2x25ul | FCT184 |
| Vector Control (EF1A) Lentivirus, 8x25ul | FCT185 |
At Kerafast, we are interested in what is happening in the scientific community around us. Periodically, we will publish mini-reviews from experts in the field on “hot topics” in our industry.
